Search
Carboplatin Treatment Options in United Kingdom
A collection of 302 research studies where Carboplatin is the interventional treatment. These studies are located in the United Kingdom . Carboplatin is used for conditions such as Non-Small Cell Lung Cancer, Ovarian Cancer and Lung Cancer.
49 - 60 of 302
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
Active Not Recruiting
Study GO43104 is a Phase III, randomized, open-label, multicenter study of lurbinectedin in combination with atezolizumab compared with atezolizumab alone administered as maintenance therapy in participants with extensive-stage small-cell lung cancer (ES-SCLC) after first-line induction therapy with carboplatin, etoposide, and atezolizumab. The study consists of 2 phases: an induction phase and a maintenance phase. Participants need to have an ongoing response or stable disease per the Response... Read More
Study GO43104 is a Phase III, randomized, open-label, multicenter study of lurbinectedin in combination with atezolizumab compared with atezolizumab alone administered as maintenance therapy in participants with extensive-stage small-cell lung cancer (ES-SCLC) after first-line induction therapy with carboplatin, etoposide, and atezolizumab. The study consists of 2 phases: an induction phase and a maintenance phase. Participants need to have an ongoing response or stable disease per the Response Evaluation Criteria in Solid Tumor (RECIST) v1.1 criteria after completion of 4 cycles of carboplatin, etoposide, and atezolizumab induction treatment in order to be considered for eligibility screening for the maintenance phase. Eligible participants will be randomized in a 1:1 ratio to receive either lurbinectedin plus atezolizumab or atezolizumab in the maintenance phase. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/23/2025
Locations: Florida Cancer Specialists, West Palm Beach, Florida +92 locations
Florida Cancer Specialists, West Palm Beach, Florida
Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital, Marietta, Georgia
Illinois Cancer Care, Peoria, Illinois
New England Cancer Specialists, Scarborough, Maine
Dana Farber Cancer Institute, Boston, Massachusetts
Cancer & Hematology Centers of Western Michigan, Grand Rapids, Michigan
Mercy Research - St. Louis, Saint Louis, Missouri
Clinical Research Alliance, Westbury, New York
Fox Chase Cancer Center, Philadelphia, Pennsylvania
Rhode Island Hospital, Providence, Rhode Island
Hollings Cancer Center, Charleston, South Carolina
Greco-Hainesworth Centers for Research, Chattanooga, Tennessee
West Clinic, Germantown, Tennessee
Sarah Cannon Research Institute / Tennessee Oncology, Nashville, Tennessee
Institut Jules Bordet, Anderlecht, Not set
Jessa Zkh (Campus Virga Jesse), Hasselt, Not set
UZ Leuven Gasthuisberg, Leuven, Not set
AZ St Maarten Campus Leopoldstr, Mechelen, Not set
CHU UCL Mont-Godinne, Mont-godinne, Not set
Vitaz, Sint Niklaas, Not set
Zentralklinik Bad Berka GmbH, Bad Berka, Not set
Evang. Lungenklinik Berlin Klinik für Pneumologie, Berlin, Not set
Helios Klinikum Emil von Behring GmbH, Berlin, Not set
Klinikum Chemnitz gGmbH, Chemnitz, Not set
KEM/Evang. Kliniken Essen Mitte gGmbH, Essen, Not set
Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH, Georgsmarienhütte, Not set
LungenClinic Großhansdorf GmbH, Großhansdorf, Not set
Krankenhaus Martha-Maria Halle-Doelau gGmbH, Halle, Not set
Universitätsklinikum Schleswig-Holstein, Lübeck, Not set
Asklepios Klinik Gauting, München-Gauting, Not set
Sotiria Thoracic Diseases Hospital of Athens, Athens, Not set
Errikos Dynan Hospital, Athens, Not set
University Hospital of Larissa, Larissa, Not set
Euromedical General Clinic of Thessaloniki, Thessaloniki, Not set
Diavalkaniko Hospital, Thessaloniki, Not set
Orszagos Koranyi Pulmonologiai Intezet, Budapest, Not set
Pécsi Tudományegyetem, Pécs, Not set
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rend.Int., Szolnok, Not set
Tudogyogyintezet Torokbalint, Torokbalint, Not set
AUSL della Romagna, Ravenna, Emilia-Romagna
ASL 3 Genovese, Genova, Liguria
Irccs Istituto Europeo di Oncologia (IEO), Milano, Lombardia
Azienda Socio Sanitaria Territoriale Niguarda (Ospedale Niguarda Ca' Granda), Milano, Lombardia
Azienda Ospedaliero Universitaria Ospedali Riuniti, Torrette Di Ancona, Marche
Chungbuk National University Hospital, Cheongju-si, Not set
Chilgok Kyungpook National University Medical Center, Daegu, Not set
Samsung Changwon Hospital, Gyeongsangnam-do, Not set
Gyeongsang National University Hospital, Gyeongsangnam-do, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Ulsan University Hosiptal, Ulsan, Not set
Health Pharma Professional Research, Cdmx, Mexico CITY (federal District)
Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde, Morelia, Not set
Uniwersyteckie Centrum Kliniczne, Gda?sk, Not set
Krakowski Szpital Specjalistyczny im sw. Jana Paw?a II, Kraków, Not set
Warminsko-Mazurskie Centrum Chorób P?uc w Olsztynie, Olsztyn, Not set
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy, Otwock, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu, Poznan, Not set
Centrum Onkologii Instytut im.Marii Sklodowskiej-Curie, Warszawa, Not set
Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruña, LA Coruna
Hospital del Mar, Barcelona, Not set
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Not set
Hospital de la Santa Creu i Sant Pau, Barcelona, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Clinico Universitario Virgen de la Victoria, Malaga, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
E-DA Hospital, Kaohsiung, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Taipei Veterans General Hospital, Taipei, Not set
Adana Baskent University Hospital, Adana, Not set
Memorial Ankara Hastanesi, Ankara, Not set
Liv Hospital Ankara, Ankara, Not set
Ankara City Hospital, Ankara, Not set
Uludag Uni Hospital, Bursa, Not set
Pamukkale University School Of Medicine, Denizli, Not set
Dicle University Faculty of Medicine, Diyarbakir, Not set
Trakya Universitesi Tip Fakultesi, Medikal Onkoloji Bilim Dali, Balkan Yerleskesi, Edirne, Not set
Ba?c?lar Medipol Mega Üniversite Hastanesi, Istanbul, Not set
Istanbul Uni Cerrahpasa Medical Faculty Hospital, Istanbul, Not set
Ac?badem Altunizade Hastanesi, Istanbul, Not set
Izmir Medical Point Hospital, Izmir, Not set
Kocaeli University Faculty of Medicine, Izmit, Not set
Goztepe Prof.Dr. Suleyman Yalcin City Hospital, Kadiköy, Not set
Medikal Park Samsun, Samsun, Not set
TC Necmettin Erbakan University Meram Medical Faculty Hospital, Selçuklu, Not set
Blackpool Victoria Hospital, Blackpool, Not set
Christie NHS Foundation Trust, GB Manchester, Not set
Castle Hill Hospital, Hull, Not set
St James University Hospital, Leeds, Not set
Leicester Royal Infirmary, Leicester, Not set
Guy's Hospital, London, Not set
Conditions: Small-Cell Lung Cancer
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)
Completed
The purpose of this study is to assess the safety and efficacy of pemetrexed + platinum chemotherapy + pembrolizumab (MK-3475) with or without lenvatinib (MK-7902/E7080) as first-line intervention in adults with metastatic nonsquamous non-small cell lung cancer.
The primary study hypotheses state that: 1) the combination of lenvatinib + platinum doublet chemotherapy + pembrolizumab prolongs Progression-free Survival (PFS) as assessed by blinded independent central review (BICR) per modified Res... Read More
The purpose of this study is to assess the safety and efficacy of pemetrexed + platinum chemotherapy + pembrolizumab (MK-3475) with or without lenvatinib (MK-7902/E7080) as first-line intervention in adults with metastatic nonsquamous non-small cell lung cancer.
The primary study hypotheses state that: 1) the combination of lenvatinib + platinum doublet chemotherapy + pembrolizumab prolongs Progression-free Survival (PFS) as assessed by blinded independent central review (BICR) per modified Response Evaluation Criteria in Solid Tumors version 1.1 (RESIST 1.1) compared to matching placebo + platinum doublet chemotherapy + pembrolizumab, and 2) the combination of lenvatinib + platinum doublet chemotherapy + pembrolizumab prolongs Overall Survival (OS) compared to matching placebo + platinum doublet chemotherapy + pembrolizumab. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: El Camino Hospital Cancer Center ( Site 0529), Mountain View, California +157 locations
El Camino Hospital Cancer Center ( Site 0529), Mountain View, California
Yale University ( Site 0519), New Haven, Connecticut
Holy Cross Hospital ( Site 0512), Fort Lauderdale, Florida
Mercy Health-Paducah Medical Oncology and Hematology ( Site 0570), Paducah, Kentucky
Henry Ford Health System ( Site 0563), Detroit, Michigan
Saint Lukes Cancer Institute ( Site 0541), Kansas City, Missouri
Broome Oncology, LLC ( Site 0562), Johnson City, New York
Sanford Health Roger Maris Cancer Center ( Site 0533), Fargo, North Dakota
Stephenson Cancer Center ( Site 0504), Oklahoma City, Oklahoma
Good Samaritan Hospital Corvallis ( Site 0521), Corvallis, Oregon
Thomas Jefferson University Hospital ( Site 0548), Philadelphia, Pennsylvania
Abington Hospital - Asplundh Cancer Center ( Site 0575), Willow Grove, Pennsylvania
West Cancer Center - East Campus ( Site 0544), Germantown, Tennessee
Parkland Health & Hospital System ( Site 0576), Dallas, Texas
UT Southwestern Medical Center ( Site 0558), Dallas, Texas
Utah Cancer Specialists ( Site 0523), Salt Lake City, Utah
West Virginia University ( Site 0526), Morgantown, West Virginia
Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 0367), Berazategui, Buenos Aires
Instituto de Investigaciones Clinicas Mar del Plata ( Site 0371), Mar del Plata, Buenos Aires
CEMIC ( Site 0370), Buenos Aires, Caba
Sanatorio Parque ( Site 0365), Rosario, Santa Fe
Hospital Aleman ( Site 0368), Buenos Aires, Not set
Instituto Medico Especializado Alexander Fleming ( Site 0369), Buenos Aires, Not set
CEMAIC ( Site 0374), Cordoba, Not set
CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica ( Site 0372), San Juan, Not set
Blacktown Hospital Western Sydney Local Health District ( Site 0008), Blacktown, New South Wales
Port Macquarie Base Hospital ( Site 0001), Port Macquarie, New South Wales
Chris OBrien Lifehouse ( Site 0006), Sydney, New South Wales
Westmead Hospital ( Site 0009), Sydney, New South Wales
Cairns Hospital ( Site 0002), Cairns, Queensland
The Prince Charles Hospital ( Site 0010), Chermside, Queensland
Ballarat Health Services ( Site 0003), Ballarat, Victoria
Moncton Hospital - Horizon Health Network ( Site 0410), Moncton, New Brunswick
Juravinski Cancer Centre ( Site 0407), Hamilton, Ontario
Kingston Health Sciences Centre ( Site 0414), Kingston, Ontario
Lakeridge Health ( Site 0406), Oshawa, Ontario
Sault Area Hospital ( Site 0413), Sault Ste Marie, Ontario
Hopital Cite de la Sante de Laval ( Site 0400), Laval, Quebec
CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0412), Montreal, Quebec
CIUSSS de la Mauricie et du Centre du Quebec ( Site 0408), Trois-Rivieres, Quebec
CHU de Quebec-Universite Laval-Hotel Dieu de Quebec ( Site 0403), Quebec, Not set
Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 0380), Temuco, Araucania
Clinica Universidad Catolica del Maule ( Site 0385), Talca, Maule
OrlandiOncologia ( Site 0381), Santiago, Region M. De Santiago
Fundacion Arturo Lopez Perez FALP ( Site 0383), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile ( Site 0382), Santiago, Region M. De Santiago
Bradford Hill Centro de Investigaciones Clinicas ( Site 0387), Santiago, Region M. De Santiago
Oncocentro ( Site 0384), Vina del Mar, Valparaiso
Centro Oncologico Antofagasta ( Site 0386), Antofagasta, Not set
Peking Union Medical College Hospital ( Site 0108), Beijing, Beijing
Cancer Hospital Chinese Academy of Medical Science ( Site 0117), Beijing, Beijing
Beijing Cancer Hospital ( Site 0120), Beijing, Beijing
The Second Hospital Affiliated to AMU ( Site 0119), Chongqing, Chongqing
First Affiliated Hospital of The Third Military Medical University ( Site 0118), Chongqing, Chongqing
Fujian Provincial Cancer Hospital ( Site 0102), Fuzhou, Fujian
Southern Medical University Nanfang Hospital ( Site 0121), Guangzhou, Guangdong
The Third Affiliated Hospital of Harbin Medical University ( Site 0100), Harbin, Heilongjiang
Henan Cancer Hospital ( Site 0112), Zhengzhou, Henan
Wuhan Union Hospital Cancer Center-Cancer Center ( Site 0123), Wuhan, Hubei
Hubei Cancer Hospital ( Site 0122), Wuhan, Hubei
Jilin Cancer Hospital ( Site 0115), Changchun, Jilin
Zhongshan Hospital Fudan University ( Site 0103), Shanghai, Shanghai
Shanghai Pulmonary Hospital ( Site 0101), Shanghai, Shanghai
Tianjin Medical University Cancer Institute & Hospital ( Site 0111), Tian Jin, Tianjin
Cancer Hospital Affiliated to Xinjiang Medical University ( Site 0110), Urumuqi, Xinjiang
The First Affiliated Hospital Zhejiang University ( Site 0109), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 0113), Hangzhou, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University ( Site 0124), Wen Zhou, Zhejiang
Centre Paul Strauss ( Site 0144), Strasbourg, Bas-Rhin
Hopital Nord du Marseille ( Site 0147), Marseille, Bouches-du-Rhone
Hopital Foch ( Site 0145), Suresnes, Hauts-de-Seine
Centre de Cancerologie du Grand Montpellier ( Site 0142), Montpellier, Herault
Hopital Laennec ( Site 0146), Nantes cedex 1, Loire-Atlantique
Hopital Robert Schuman ( Site 0143), Vantoux, Moselle
Hopital Cardiologique Louis Pradel ( Site 0141), Bron, Rhone-Alpes
L'hopital Nord-Ouest - Centre Hospitalier de Villefranche sur Saone ( Site 0149), Villefranche sur Saone, Rhone
Hopital Cochin ( Site 0140), Paris, Not set
Klinikum Esslingen GmbH ( Site 0164), Esslingen, Baden-Wurttemberg
Krankenhaus Nordwest ( Site 0169), Frankfurt, Hessen
Pius Hospital Oldenburg ( Site 0170), Oldenburg, Niedersachsen
Uniklinik RWTH Aachen ( Site 0160), Aachen, Nordrhein-Westfalen
Universitaetsklinikum des Saarlandes ( Site 0165), Homburg, Saarland
Krankenhaus Martha Maria Halle-Doelau ( Site 0166), Halle, Sachsen-Anhalt
LungenClinic Grosshansdorf GmbH ( Site 0171), Grosshansdorf, Schleswig-Holstein
Hamato-Onkologie Hamburg Prof. Laack und Partner ( Site 0161), Hamburg, Not set
Soroka Medical Center ( Site 0222), Beer Sheva, Not set
Rambam Medical Center ( Site 0223), Haifa, Not set
Shaare Zedek Medical Center-Oncology ( Site 0229), Jerusalem, Not set
Meir Medical Center ( Site 0221), Kfar Saba, Not set
Holy Family Hospital ( Site 0228), Nazareth, Not set
Rabin Medical Center ( Site 0224), Petah Tikva, Not set
Sheba Medical Center ( Site 0220), Ramat Gan, Not set
Sourasky Medical Center ( Site 0225), Tel Aviv, Not set
Shamir Medical Center-Assaf Harofeh ( Site 0227), Zerifin, Not set
National Hospital Organization Nagoya Medical Center ( Site 0017), Nagoya, Aichi
Fujita Health University Hospital ( Site 0016), Toyoake, Aichi
National Cancer Center Hospital East ( Site 0024), Kashiwa, Chiba
Kanazawa University Hospital ( Site 0018), Kanazawa, Ishikawa
Osaka Habikino Medical Center ( Site 0020), Habikino, Osaka
Kansai Medical University Hospital ( Site 0022), Hirakata, Osaka
Niigata Cancer Center Hospital ( Site 0019), Niigata, Not set
National Cancer Center Hospital ( Site 0026), Tokyo, Not set
Tokyo Metropolitan Komagome Hospital ( Site 0015), Tokyo, Not set
The Cancer Institute Hospital of JFCR ( Site 0021), Tokyo, Not set
Wakayama Medical University Hospital ( Site 0025), Wakayama, Not set
Chungbuk National University Hospital ( Site 0062), Cheongju si, Chungbuk
National Cancer Center ( Site 0061), Goyang-si, Kyonggi-do
The Catholic University of Korea St. Vincent s Hospital ( Site 0064), Gyeonggi-do, Kyonggi-do
Severance Hospital Yonsei University Health System ( Site 0063), Seoul, Not set
Tauranga Hospital ( Site 0004), Tauranga, Bay Of Plenty
Auckland City Hospital ( Site 0011), Auckland, Not set
Centrum Onkologii im.prof. F. Lukaszczyka w Bydgoszczy ( Site 0601), Bydgoszcz, Kujawsko-pomorskie
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii ( Site 0613), Lodz, Lodzkie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 0603), Warszawa, Mazowieckie
Pleszewskie Centrum Medyczne w Pleszewie Sp. z o.o. ( Site 0615), Pleszew, Wielkopolskie
MED-POLONIA Sp. z o.o. ( Site 0609), Poznan, Wielkopolskie
Szpital Wojewodzki im. Mikolaja Kopernika ( Site 0602), Koszalin, Zachodniopomorskie
Leningrad Regional Oncology Center ( Site 0271), Saint Petersburg, Leningradskaya Oblast
Moscow Regional Oncological Dispensary ( Site 0274), Balashikha, Moskovskaya Oblast
City Clinical Hospital 1 na. NI. Pirogov ( Site 0270), Moscow, Moskva
Central Clinical Hospital with outpatient Clinic ( Site 0262), Moscow, Moskva
National Medical Research Radiology Centre ( Site 0260), Moscow, Moskva
FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 0264), Moscow, Moskva
Nizhniy Novgorod Region Oncology Dispensary ( Site 0272), Nizhniy Novgorod, Nizhegorodskaya Oblast
Omsk Clinical Oncology Dispensary ( Site 0267), Omsk, Omskaya Oblast
Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 0269), Saint Petersburg, Sankt-Peterburg
First Pavlov State Medical University of Saint Petersburg-Department of Oncology ( Site 0273), Saint-Petersburg, Sankt-Peterburg
SAHI Republican Clinical Oncological Dispensary of the MoH of RT ( Site 0261), Kazan, Tatarstan, Respublika
ICO L Hospitalet ( Site 0234), Hospitalet de Llobregat, Barcelona
Complejo Hospitalario Universitario A Coruna ( Site 0239), A Coruna, La Coruna
Hospital Universitario Insular de Gran Canaria ( Site 0244), Las Palmas de Gran Canaria, Las Palmas
Hospital General Universitario de Valencia ( Site 0231), Valencia, Valenciana, Comunitat
Hospital Universitario La Fe ( Site 0233), Valencia, Valenciana, Comunitat
Hospital General Universitario de Alicante ( Site 0240), Alicante, Not set
Hospital Santa Creu i Sant Pau ( Site 0241), Barcelona, Not set
Hospital General Universitario Gregorio Maranon ( Site 0237), Madrid, Not set
Hospital Clinico San Carlos ( Site 0235), Madrid, Not set
Hospital Universitario La Paz ( Site 0236), Madrid, Not set
Complejo Hospitalario de Malaga ( Site 0238), Malaga, Not set
Hospital Universitario Miguel Servet ( Site 0242), Zaragoza, Not set
Cukurova Universitesi Tıp Fakultesi Balcalı Hastanesi ( Site 0314), Adana, Not set
Hacettepe Universitesi Tıp Fakultesi ( Site 0316), Ankara, Not set
Ankara Universitesi Tip Fakultesi. ( Site 0317), Ankara, Not set
Ankara Sehir Hastanesi ( Site 0323), Ankara, Not set
Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0312), Istanbul, Not set
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 0310), Istanbul, Not set
Ege Universitesi Tip Fakultesi ( Site 0313), Izmir, Not set
Inonu Universitesi Medical Fakultesi ( Site 0318), Malatya, Not set
Cambridge University Hospitals NHS Trust ( Site 0293), Cambridge, Cambridgeshire
North Middlesex University Hospital NHS Trust ( Site 0291), London, London, City Of
Guys and St Thomas NHS Foundation Trust ( Site 0280), London, London, City Of
St Georges University Hospitals NHS Foundation Trust. ( Site 0292), London, London, City Of
Aberdeen Royal Infirmary ( Site 0288), Aberdeen, Scotland
Leeds Teaching Hospital NHS Trust. St. James University Hospital ( Site 0276), Leeds, Not set
Leicester Royal Infirmary ( Site 0284), Leicester, Not set
Christie NHS Foundation Trust ( Site 0275), Manchester, Not set
Nottingham City Hospital Campus ( Site 0287), Nottingham, Not set
The Clatterbridge Cancer Centre NHS Foundation Trust ( Site 0286), Wirral, Not set
Conditions: Nonsquamous Non-small Cell Lung Cancer
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
Recruiting
This is a Phase III, 2-arm, randomised, open-label, multicentre, global study assessing the efficacy and safety of neoadjuvant Dato-DXd plus durvalumab followed by adjuvant durvalumab with or without chemotherapy compared with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab with or without chemotherapy in participants with previously untreated TNBC or hormone receptor-low/HER2-negative breast cancer.
This is a Phase III, 2-arm, randomised, open-label, multicentre, global study assessing the efficacy and safety of neoadjuvant Dato-DXd plus durvalumab followed by adjuvant durvalumab with or without chemotherapy compared with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab with or without chemotherapy in participants with previously untreated TNBC or hormone receptor-low/HER2-negative breast cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: Research Site, Daphne, Alabama +355 locations
Research Site, Daphne, Alabama
Research Site, Goodyear, Arizona
Research Site, Phoenix, Arizona
Research Site, Tucson, Arizona
Research Site, Jonesboro, Arkansas
Research Site, Rogers, Arkansas
Research Site, Bakersfield, California
Research Site, Fullerton, California
Research Site, Irvine, California
Research Site, Los Angeles, California
Research Site, Los Angeles, California
Research Site, Newport Beach, California
Research Site, Orange, California
Research Site, Santa Barbara, California
Research Site, Santa Rosa, California
Research Site, Sylmar, California
Research Site, Torrance, California
Research Site, Van Nuys, California
Research Site, Aurora, Colorado
Research Site, Fort Collins, Colorado
Research Site, Longmont, Colorado
Research Site, Bridgeport, Connecticut
Research Site, New Haven, Connecticut
Research Site, Newark, Delaware
Research Site, Fort Myers, Florida
Research Site, Jacksonville, Florida
Research Site, Jacksonville, Florida
Research Site, Port Saint Lucie, Florida
Research Site, Saint Petersburg, Florida
Research Site, Tallahassee, Florida
Research Site, West Palm Beach, Florida
Research Site, Atlanta, Georgia
Research Site, Atlanta, Georgia
Research Site, Chicago Ridge, Illinois
Research Site, Dyer, Indiana
Research Site, Des Moines, Iowa
Research Site, Edgewood, Kentucky
Research Site, Louisville, Kentucky
Research Site, Baton Rouge, Louisiana
Research Site, Annapolis, Maryland
Research Site, Boston, Massachusetts
Research Site, Detroit, Michigan
Research Site, Grand Rapids, Michigan
Research Site, Traverse City, Michigan
Research Site, Burnsville, Minnesota
Research Site, Minneapolis, Minnesota
Research Site, Columbia, Missouri
Research Site, Saint Louis, Missouri
Research Site, Omaha, Nebraska
Research Site, Henderson, Nevada
Research Site, Camden, New Jersey
Research Site, East Brunswick, New Jersey
Research Site, New Brunswick, New Jersey
Research Site, Santa Fe, New Mexico
Research Site, Commack, New York
Research Site, New York, New York
Research Site, Charlotte, North Carolina
Research Site, Durham, North Carolina
Research Site, Winston-Salem, North Carolina
Research Site, Blue Ash, Ohio
Research Site, Canton, Ohio
Research Site, Eugene, Oregon
Research Site, Portland, Oregon
Research Site, Horsham, Pennsylvania
Research Site, Philadelphia, Pennsylvania
Research Site, Pittsburgh, Pennsylvania
Research Site, Providence, Rhode Island
Research Site, Chattanooga, Tennessee
Research Site, Nashville, Tennessee
Research Site, Nashville, Tennessee
Research Site, Austin, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, El Paso, Texas
Research Site, Flower Mound, Texas
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Irving, Texas
Research Site, San Antonio, Texas
Research Site, Webster, Texas
Research Site, Fairfax, Virginia
Research Site, Norfolk, Virginia
Research Site, Richmond, Virginia
Research Site, Roanoke, Virginia
Research Site, Winchester, Virginia
Research Site, Tacoma, Washington
Research Site, Madison, Wisconsin
Research Site, Darlinghurst, Not set
Research Site, East Melbourne, Not set
Research Site, Heidelberg, Not set
Research Site, Herston, Not set
Research Site, Nedlands, Not set
Research Site, Waratah, Not set
Research Site, Feldkirch, Not set
Research Site, Graz, Not set
Research Site, Innsbruck, Not set
Research Site, Linz, Not set
Research Site, Salzburg, Not set
Research Site, Antwerpen, Not set
Research Site, Brasschaat, Not set
Research Site, Charleroi, Not set
Research Site, Gent, Not set
Research Site, Leuven, Not set
Research Site, Libramont-Chevigny, Not set
Research Site, Brasilia, Not set
Research Site, Curitiba, Not set
Research Site, Fortaleza, Not set
Research Site, Londrina, Not set
Research Site, Natal, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Ribeirão Preto, Not set
Research Site, Santo Andre, Not set
Research Site, São Paulo, Not set
Research Site, Taubaté, Not set
Research Site, Vitória, Not set
Research Site, Plovdiv, Not set
Research Site, Shumen, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Vratza, Not set
Research Site, Calgary, Alberta
Research Site, Abbotsford, British Columbia
Research Site, Vancouver, British Columbia
Research Site, St. John's, Newfoundland and Labrador
Research Site, Barrie, Ontario
Research Site, London, Ontario
Research Site, Oshawa, Ontario
Research Site, Toronto, Ontario
Research Site, Levis, Quebec
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Sherbrooke, Quebec
Research Site, St-Jerome, Quebec
Research Site, Saskatoon, Saskatchewan
Research Site, Montreal, Not set
Research Site, Ottawa, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Bengbu, Not set
Research Site, Changchun, Not set
Research Site, Changsha, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Harbin, Not set
Research Site, Hefei, Not set
Research Site, Jinan, Not set
Research Site, Kunming, Not set
Research Site, Linhai, Not set
Research Site, Nanchang, Not set
Research Site, Nanchang, Not set
Research Site, Nanjing, Not set
Research Site, Nanjing, Not set
Research Site, Nanning, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Shenyang, Not set
Research Site, Shijiazhuang, Not set
Research Site, Suining, Not set
Research Site, Suzhou, Not set
Research Site, Tianjin, Not set
Research Site, Urumqi, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Xintai, Not set
Research Site, Zhaoqing, Not set
Research Site, Zhengzhou, Not set
Research Site, Avignon, Not set
Research Site, Bayonne, Not set
Research Site, Caen Cedex 5, Not set
Research Site, Clermont Ferrand, Not set
Research Site, Limoges, Not set
Research Site, Lyon, Not set
Research Site, Marseille, Not set
Research Site, Montpellier, Not set
Research Site, Nice, Not set
Research Site, Paris, Not set
Research Site, Reims Cedex, Not set
Research Site, Saint Herblain, Not set
Research Site, Toulouse, Not set
Research Site, Vandoeuvre les Nancy, Not set
Research Site, Villejuif Cedex, Not set
Research Site, Augsburg, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Dessau-Roßlau, Not set
Research Site, Dresden, Not set
Research Site, Erlangen, Not set
Research Site, Essen, Not set
Research Site, Esslingen am Neckar, Not set
Research Site, Frankfurt am Main, Not set
Research Site, Freiburg, Not set
Research Site, Freiburg, Not set
Research Site, Hamburg, Not set
Research Site, Hannover, Not set
Research Site, Hannover, Not set
Research Site, Heidelberg, Not set
Research Site, Kiel, Not set
Research Site, Mainz, Not set
Research Site, Mannheim, Not set
Research Site, München, Not set
Research Site, München, Not set
Research Site, Münster, Not set
Research Site, Trier, Not set
Research Site, Ulm, Not set
Research Site, Hong Kong, Not set
Research Site, Hong Kong, Not set
Research Site, Kwai Chung, Not set
Research Site, Budapest, Not set
Research Site, Kecskemét, Not set
Research Site, Miskolc, Not set
Research Site, Nyíregyháza, Not set
Research Site, Salgótarján, Not set
Research Site, Szekszárd, Not set
Research Site, Bengaluru, Not set
Research Site, Dehradun, Not set
Research Site, Delhi, Not set
Research Site, Delhi, Not set
Research Site, Kolkata, Not set
Research Site, Kolkata, Not set
Research Site, Marg Jaipur, Not set
Research Site, Nagpur, Not set
Research Site, Nashik, Not set
Research Site, Puducherry, Not set
Research Site, Thiruvananthapuram, Not set
Research Site, Vadodara, Not set
Research Site, Empoli, Not set
Research Site, Lucca, Not set
Research Site, Macerata, Not set
Research Site, Milano, Not set
Research Site, Modena, Not set
Research Site, Napoli, Not set
Research Site, Padova, Not set
Research Site, Roma, Not set
Research Site, Rozzano, Not set
Research Site, Torino, Not set
Research Site, Tricase, Not set
Research Site, Udine, Not set
Research Site, Akashi-shi, Not set
Research Site, Akita-shi, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chiba-shi, Not set
Research Site, Chuo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Fukushima-shi, Not set
Research Site, Gifu-shi, Not set
Research Site, Hidaka-shi, Not set
Research Site, Hirakata-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Isehara-shi, Not set
Research Site, Kashiwa, Not set
Research Site, Koto-ku, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Kurume-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Matsuyama-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Niigata-shi, Not set
Research Site, Okayama, Not set
Research Site, Osaka-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Shinagawa-ku, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Sunto-gun, Not set
Research Site, Tsu-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Daegu, Not set
Research Site, Goyang-si, Not set
Research Site, Seongnam, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, George Town, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuching, Not set
Research Site, Selangor, Not set
Research Site, Bialystok, Not set
Research Site, Bydgoszcz, Not set
Research Site, Gdańsk, Not set
Research Site, Gdynia, Not set
Research Site, Kraków, Not set
Research Site, Tomaszów Mazowiecki, Not set
Research Site, Warszawa, Not set
Research Site, Wroclaw, Not set
Research Site, Łódź, Not set
Research Site, Singapore, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, Granada, Not set
Research Site, Hospitalet deLlobregat, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Santiago de Compostela, Not set
Research Site, Sevilla, Not set
Research Site, Zaragoza, Not set
Research Site, Baden, Not set
Research Site, Basel, Not set
Research Site, Bern, Not set
Research Site, Frauenfeld, Not set
Research Site, Genolier, Not set
Research Site, Rennaz, Not set
Research Site, Changhua, Not set
Research Site, Kaohsiung, Not set
Research Site, Taichung, Not set
Research Site, Tainan, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Dusit, Not set
Research Site, Muang, Not set
Research Site, Songkhla, Not set
Research Site, Adapazari, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Istanbul, Not set
Research Site, Kayseri, Not set
Research Site, Samsun, Not set
Research Site, Birmingham, Not set
Research Site, Cardiff, Not set
Research Site, Edinburgh, Not set
Research Site, Guildford, Not set
Research Site, Lancaster, Not set
Research Site, London, Not set
Research Site, Northampton, Not set
Research Site, Oxford, Not set
Research Site, Taunton, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh city, Not set
Research Site, Vinh, Not set
Conditions: Breast Cancer
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
Active Not Recruiting
This randomized, active-controlled, multicenter, open-label, Phase III study is designed to investigate the efficacy and safety of alectinib compared with platinum-based in the adjuvant setting. Participants in the experimental arm will receive alectinib at 600 mg orally twice daily (BID) taken with food for 24 months.
Participants in the control arm will receive one of the protocol specified platinum based chemotherapy regimens for 4 cycles. Following treatment completion, participants will be... Read More
This randomized, active-controlled, multicenter, open-label, Phase III study is designed to investigate the efficacy and safety of alectinib compared with platinum-based in the adjuvant setting. Participants in the experimental arm will receive alectinib at 600 mg orally twice daily (BID) taken with food for 24 months.
Participants in the control arm will receive one of the protocol specified platinum based chemotherapy regimens for 4 cycles. Following treatment completion, participants will be followed up for their disease until disease recurrence. At the time of disease recurrence, participants will enter a survival follow-up until death, withdrawal of consent or study closure, whichever occurs earlier. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: Rush University Medical Center, Chicago, Illinois +114 locations
Rush University Medical Center, Chicago, Illinois
MGH Cancer Center, Boston, Massachusetts
AHN Cancer Institute ? Allegheny General Hospital, Pittsburgh, Pennsylvania
Chris O'Brien Lifehouse, Camperdown, New South Wales
GenesisCare North Shore, St Leonards, New South Wales
Peter MacCallum Cancer Center, Melbourne, Victoria
Krankenhaus Nord - Klinik Floridsdorf, Wien, Not set
Healthcare Institution ?Gomel Regional Clinical Oncologic Dispensary?, Gomel, Homyel'skaya Voblasts'
Healthcare Institution Grodno University Hospital, Grodno, Hrodzyenskaya Voblasts'
Vitebsk Regional Clinical Oncology Dispensary, Vitebsk, Vitsyebskaya Voblasts'
Clinical center University of Sarajevo, Sarajevo, Not set
Beijing Cancer Hospital, Beijing, Not set
Jilin Cancer Hospital, Changchun, Not set
West China Hospital, Sichuan University, Chengdu, Not set
Fujian Medical University Union Hospital, Fujian, Not set
Guangdong General Hospital, Guangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou, Not set
Shandong Cancer Hospital, Jinan, Not set
Shanghai Chest Hospital, Shanghai, Not set
Zhongshan Hospital Fudan University, Shanghai, Not set
Shenzhen People's Hospital, Shenzhen, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan City, Not set
First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Not set
Odense Universitetshospital, Onkologisk Afdeling R, Odense C, Not set
Kasr Eieny Uni Hospital, Cairo, Not set
CHU Angers, Angers, Not set
Hopital Nord AP-HM, Marseille, Not set
Hopital Bichat Claude Bernard, Paris, Not set
Institut Gustave Roussy, Villejuif cedex, Not set
Klinikum Chemnitz gGmbH, Chemnitz, Not set
Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH, Georgsmarienhütte, Not set
Thoraxklinik Heidelberg gGmbH, Heidelberg, Not set
Fachklinik für Lungenerkrankungen, Immenhausen, Not set
Metropolitan Hospital, Athens, Not set
Theageneio Hospital, Thessaloniki, Not set
Orszagos Onkologiai Intezet, Budapest, Not set
Hetenyi Geza County Hospital, Szolnok, Not set
Rambam Health Care Campus, Haifa, Not set
Meir Medical Center, Kfar Saba, Not set
Az. Osp. Monaldi, Napoli, Campania
Azienda Ospedaliera San Camillo Forlanini - Unità Operativa Complessa di Pneumologia Oncologica 1, Roma, Lazio
Irccs Istituto Europeo di Oncologia (IEO), Milano, Lombardia
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, Piemonte
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia, Perugia, Umbria
Aichi Cancer Center, Aichi, Not set
National Cancer Center Hospital East, Chiba, Not set
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
Hiroshima University Hospital, Hiroshima, Not set
National Hospital Organization Hokkaido Cancer Center, Hokkaido, Not set
National Hospital Organization Himeji Medical Center, Hyogo, Not set
Kanagawa Cancer Center, Kanagawa, Not set
Kumamoto University Hospital, Kumamoto, Not set
Kyoto University Hospital, Kyoto, Not set
Sendai Kousei Hospital, Miyagi, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Okayama University Hospital, Okayama, Not set
Osaka City General Hospital, Osaka, Not set
Shizuoka Cancer Center, Shizuoka, Not set
National Cancer Center Hospital, Tokyo, Not set
Juntendo University Hospital, Tokyo, Not set
The Cancer Institute Hospital of JFCR, Tokyo, Not set
Tokyo Medical University Hospital, Tokyo, Not set
Almaty Oncology Center, Almaty, Not set
National Cancer Center, Gyeonggi-do, Not set
Seoul National University Bundang Hospital, Gyeonggi-do, Not set
Ajou University Medical Center, Gyeonggi-do, Not set
Gachon University Gil Medical Center, Incheon, Not set
Chonnam National University Hwasun Hospital, Jeollanam-do, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Korea University Guro Hospital, Seoul, Not set
PHI University Clinic of Radiotherapy and Oncology; Malignant diseases of thorax, Skopje, Not set
Private Health Organization Acibadem Sistina Hospital, Skopje, Not set
Gdanski Uniwersytet Medyczny, Gda?sk, Not set
Krakowski Szpital Specjalistyczny im sw. Jana Paw?a II, Kraków, Not set
Warminsko-Mazurskie Centrum Chorób P?uc w Olsztynie, Olsztyn, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu, Poznan, Not set
Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad, Warszawa, Not set
Prof Dr I Chiricuta Institute of Oncology, Cluj-napoca, Not set
Oncomed SRL, Timisoara, Not set
Moscow City Oncology Hospital #62, Moscovskaya Oblast, Moskovskaja Oblast
FSBI Russian Oncology Research Center n.a. Blokhin of MOH RF, Moscow, Moskovskaja Oblast
P.A. Gertsen Cancer Research Inst., Moscow, Moskovskaja Oblast
SPb City Clin Onc Dsp, Sankt-peterburg, Sankt Petersburg
Pavlov First Saint Petersburg State Medical University, St. Petersburg, Sankt Petersburg
Scientific Research Oncology Institute named after N.N. Petrov, St. Petersburg, Sankt Petersburg
GUZ Regional clinical hospital # 1, Krasnodar, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital de la Santa Creu i Sant Pau, Barcelona, Not set
Hospital Universitari Germans Trias i Pujol, Barcelona, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Chang Gung Memorial Foundation - Kaohsiung, Kaohsiung, Not set
China Medical University Hospital, Taichung, Not set
National Taiwan University Hospital, Taipei, Not set
Chang Gung Medical Foundation - Linkou, Taoyuan, Not set
Taichung Veterans General Hospital, Xitun Dist., Not set
Ramathibodi Hospital, Bangkok, Not set
Siriraj Hospital, Bangkok, Not set
Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital, Adana, Not set
Hacettepe Uni Medical Faculty Hospital, Ankara, Not set
Ankara Ataturk Chest Diseases Training and Research Hospital, Ankara, Not set
Istanbul Uni Cerrahpasa Medical Faculty Hospital, Istanbul, Not set
Ege Uni Medical Faculty Hospital, Izmir, Not set
Izmir Suat Seren Chest Diseases and Surgery Research Hospital, Izmir, Not set
Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department, Malatya, Not set
Medikal Park Samsun, Samsun, Not set
Medical center of Yuriy Spizhenko LLC, Kapitanovka Village, KIEV Governorate
Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipropetrovsk, Not set
Kyiv City Clinical Oncological Center, Kyiv, Not set
RCI Sumy Regional Clinical Oncological Dispensary, Sumy, Not set
Vinnytsia Regional Clinical Oncology Dispensary, Vinnytsia, Not set
Guys Hospital, London, Not set
Wythenshaw Hospital, Manchester, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
Active Not Recruiting
The purpose of study is to evaluate the safety, pharmacokinetics, and preliminary efficacy of Amivantamab as a monotherapy and in combination with lazertinib, and to determine the recommended Phase 2 dose (RP2D) (monotherapy), recommended Phase 2 combination dose (RP2CD) (combination therapy), and to determine recommended Phase 2 Dose (RP2q3W) with combination chemotherapy (Amivantamab in combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants wit... Read More
The purpose of study is to evaluate the safety, pharmacokinetics, and preliminary efficacy of Amivantamab as a monotherapy and in combination with lazertinib, and to determine the recommended Phase 2 dose (RP2D) (monotherapy), recommended Phase 2 combination dose (RP2CD) (combination therapy), and to determine recommended Phase 2 Dose (RP2q3W) with combination chemotherapy (Amivantamab in combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small cell lung cancer (NSCLC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/17/2025
Locations: Not set, Duarte, California +69 locations
Not set, Duarte, California
Not set, La Jolla, California
Not set, Orange, California
Not set, Santa Monica, California
Not set, West Hollywood, California
Not set, Tampa, Florida
Not set, Chicago, Illinois
Not set, Bethesda, Maryland
Not set, Boston, Massachusetts
Not set, Detroit, Michigan
Not set, Rochester, Minnesota
Not set, Saint Louis, Missouri
Not set, New York, New York
Not set, Portland, Oregon
Not set, Philadelphia, Pennsylvania
Not set, Houston, Texas
Not set, Fairfax, Virginia
Not set, Camperdown, Not set
Not set, Heidelberg, Not set
Not set, Kogarah, Not set
Not set, Murdoch, Not set
Not set, Woolloongabba, Not set
Not set, Toronto, Ontario
Not set, Beijing, Not set
Not set, Changchun, Not set
Not set, Changsha, Not set
Not set, Chengdu, Not set
Not set, Chongqing, Not set
Not set, Guangzhou, Not set
Not set, Hangzhou, Not set
Not set, Hefei, Not set
Not set, Nanchang, Not set
Not set, Nanjing, Not set
Not set, Wuhan, Not set
Not set, Zhengzhou, Not set
Not set, Bordeaux, Not set
Not set, Dijon, Not set
Not set, Lyon Cedex 8, Not set
Not set, Marseille, Not set
Not set, Paris, Not set
Not set, Saint-Herblain Cedex, Not set
Not set, Villejuif Cedex, Not set
Not set, Chuo Ku, Not set
Not set, Hyogo, Not set
Not set, Kashiwa, Not set
Not set, Kurume, Not set
Not set, Nagoya Shi, Not set
Not set, Niigata, Not set
Not set, Osaka, Not set
Not set, Tokyo, Not set
Not set, Wakayama, Not set
Not set, Yonago, Not set
Not set, Cheongju-si, Not set
Not set, Goyang si, Not set
Not set, Incheon, Not set
Not set, Seongnam-si, Not set
Not set, Seoul, Not set
Not set, A Coruna, Not set
Not set, Barcelona, Not set
Not set, Madrid, Not set
Not set, Malaga, Not set
Not set, Santander, Not set
Not set, Seville, Not set
Not set, Kaohsiung, Not set
Not set, Taichung, Not set
Not set, Taipei City, Not set
Not set, Taipei, Not set
Not set, Manchester, Not set
Not set, Newcastle upon Tyne, Not set
Not set, Sutton, Not set
Conditions: Non-Small-Cell Lung Cancer
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer
Recruiting
The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in addition to pembrolizumab and carboplatin in participants with recurrent/metastatic head and neck cancer. The study will also confirm the recommended Phase 2 combination dose (RP2CD) for amivantamab in addition to paclitaxel.
The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in addition to pembrolizumab and carboplatin in participants with recurrent/metastatic head and neck cancer. The study will also confirm the recommended Phase 2 combination dose (RP2CD) for amivantamab in addition to paclitaxel. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/17/2025
Locations: University of California at San Diego Moores Cancer Center, La Jolla, California +54 locations
University of California at San Diego Moores Cancer Center, La Jolla, California
University of Colorado Denver Anschultz Medical Campus, Aurora, Colorado
Yale Cancer Center, New Haven, Connecticut
The University of Chicago Medical Center (UCMC), Chicago, Illinois
University of Maryland School of Medicine, Baltimore, Maryland
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Karmanos Cancer Institute, Detroit, Michigan
Washington University School Of Medicine, Saint Louis, Missouri
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Cleveland Clinic, Cleveland, Ohio
University of Utah Huntsman Cancer Institute, Salt Lake City, Utah
University of Virginia, Charlottesville, Virginia
Virginia Cancer Specialists, Fairfax, Virginia
Beijing Cancer Hospital of Peking University, Beijing, Not set
West China School of Medicine/West China Hospital, Sichuan University, Cheng Du Shi, Not set
Linyi Cancer Hospital, Linyi, Not set
Fudan Cancer Hospital, ShangHai, Not set
Shanghai East Hospital, Shanghai, Not set
Union Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Not set
Institut Sainte Catherine, Avignon Cedex 9, Not set
Centre Oscar Lambret, Lille, Not set
CHU Nantes, Nantes Cedex 1, Not set
Institut Curie, PARIS Cedex 5, Not set
Gustave Roussy, Villejuif Cedex, Not set
Universitaetsklinikum Essen, Essen, Not set
Universitaetsklinikum Leipzig, Leipzig, Not set
Klinikum der Landeshauptstadt Stuttgart, Stuttgart, Not set
Aichi Cancer Center, Nagoya, Not set
Tokyo Medical University Hospital, Tokyo, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Pantai Hospital Kuala Lumpur, Kuala Lumpur, Not set
University Malaya Medical Centre, Kuala Lumpur, Not set
Uniwersyteckie Centrum Kliniczne, Gdansk, Not set
Centrum Onkologii Instytut im M Sklodowskiej Curie Oddzial w Gliwicach, Gliwice, Not set
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warszawa, Not set
Hosp Univ Vall D Hebron, Barcelona, Not set
Inst. Cat. Doncologia-H Duran I Reynals, Barcelona, Not set
Hosp. Univ. Ramon Y Cajal, Madrid, Not set
Hosp. Univ. 12 de Octubre, Madrid, Not set
Changhua Christian Hospital, ChangHua, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Linkou Chang Gung Memorial Hospital, Taoyuan, Not set
Addenbrooke's Hospital, Cambridge, Not set
The Royal Surrey County Hospital NHS Foundation Trust, Guildford, Not set
Royal Marsden Hospital, London, Not set
Imperial College London and Imperial College Healthcare NHS Trust, London, Not set
University College London Hospitals, London, Not set
The Christie Nhs Foundation Trust, Manchester, Not set
Royal Marsden Hospital, Sutton, Not set
Conditions: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Recruiting
The purpose of this study is to assess the anti-tumor activity and safety of amivantamab which will be administered as a co-formulation with recombinant human hyaluronidase PH20 (rHuPH20) (subcutaneous co-formulation \[SC-CF\]) in combination treatment (all cohorts except Cohort 4) and to characterize the safety of amivantamab SC-CF (Cohort 4).
The purpose of this study is to assess the anti-tumor activity and safety of amivantamab which will be administered as a co-formulation with recombinant human hyaluronidase PH20 (rHuPH20) (subcutaneous co-formulation \[SC-CF\]) in combination treatment (all cohorts except Cohort 4) and to characterize the safety of amivantamab SC-CF (Cohort 4). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/17/2025
Locations: University of California at San Diego, La Jolla, California +109 locations
University of California at San Diego, La Jolla, California
University of California Irvine, Orange, California
Stanford Cancer Institute, Stanford, California
Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital, Washington, District of Columbia
Baptist Lynn Cancer Institute, Boca Raton, Florida
Mount Sinai Medical Center, Miami Beach, Florida
AdventHealth, Orlando, Florida
H. Lee Moffitt Cancer & Research Institute, Tampa, Florida
University of Kansas Cancer Center, Westwood, Kansas
Sidney Kimmel Cancer Center - Bayview Campus, Baltimore, Maryland
Boston Medical Center, Boston, Massachusetts
Washington University School Of Medicine, Saint Louis, Missouri
Hackensack University Medical Center, Hackensack, New Jersey
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Hematology-Oncology Associates of CNY, East Syracuse, New York
Novant Health, Charlotte, North Carolina
Novant Health, Winston-Salem, North Carolina
Cleveland Clinic, Cleveland, Ohio
Cleveland Clinic, Cleveland, Ohio
Cleveland Clinic, Mayfield Heights, Ohio
Cleveland Clinic, Warrensville Heights, Ohio
The Huntsman Cancer Institute, Salt Lake City, Utah
Virginia Cancer Specialists, Fairfax, Virginia
Providence Regional Cancer Partnership, Everett, Washington
Virginia Mason Medical Center, Seattle, Washington
Swedish Cancer Institute, Seattle, Washington
Fundacao Pio XII, Barretos, Not set
PERSONAL Oncologia de Precisao e Personalizada, Belo Horizonte, Not set
Instituto do Cancer de Londrina Hospital do Cancer de Londrina, Londrina, Not set
Associacao Hospitalar Moinhos de Vento, Porto Alegre, Not set
Instituto D Or de Pesquisa e Ensino IDOR, Rio de Janeiro, Not set
Instituto D Or de Pesquisa e Ensino IDOR, Salvador, Not set
Hospital Alemao Oswaldo Cruz, Sao Paulo, Not set
Impar Servicos Hospitalares SA Hospital Nove de Julho, Sao Paulo, Not set
Fundacao Antonio Prudente A C Camargo Cancer Center, Sao Paulo, Not set
Affiliated Hospital of Hebei University, Bao Ding Shi, Not set
Jilin cancer hospital, Changchun, Not set
Sichuan Cancer Hospital, Chengdu, Not set
West China Hospital Sichuan University, Chengdu, Not set
The First Affiliated Hospital of PLA Army Medical University, ChongQing, Not set
The First Affiliated Hospital Sun Yat sen University, Guangzhou, Not set
The First Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, Not set
Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, Not set
Harbin medical university cancer hospital, Harbin, Not set
Huizhou Municipal Central Hospital, Huizhou, Not set
Liuzhou people's Hospital, Liuzhou, Not set
Fudan University Shanghai Cancer Center, Shanghai, Not set
Tianjin Medical University General Hospital, Tianjin, Not set
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Not set
Union Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Not set
Hospital of Jiangnan University, Wuxi, Not set
The First Affiliated Hospital of Xian Jiaotong University, XI An, Not set
Yantai Yuhuangding Hospital, Yantai, Not set
Centre Francois Baclesse, Caen Cedex 05, Not set
Centre Georges-François Leclerc, Dijon, Not set
Institut de Cancérologie du Gard, Nîmes, Not set
Institut Curie, PARIS Cedex 5, Not set
Institut de cancerologie de l'ouest, Saint-Herblain Cedex, Not set
Gustave Roussy, Villejuif Cedex, Not set
Evangelische Lungenklinik Berlin, Berlin, Not set
LungenClinic Grosshansdorf GmbH, Grosshandorf, Not set
Lungenfachklinik Immenhausen, Immenhausen, Not set
Universitaetsklinikum Koelnt, Koeln, Not set
Klinikum Würzburg Mitte gGmbH Standort Missioklinik, Wuerzburg, Not set
Rambam Medical Center, Haifa, Not set
Shaare Zedek Medical Center, Jerusalem, Not set
Meir Medical Center, Kfar Saba, Not set
Rabin Medical Center, Petah Tikva, Not set
Sheba Medical Center, Ramat Gan, Not set
Policlinico Hospital San Martino- IRCCS for Oncology, Genova, Not set
Ospedale San Raffaele, Milano, Not set
ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set
Azienda Ospedaliera San Gerardo, Monza, Not set
Azienda Ospedaliera Specialistica dei Colli, Naples, Not set
National Hospital Organization Himeji Medical Center, Himeji, Not set
Matsusaka Municipal Hospital, Matsusaka, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Shizuoka Cancer Center, Shizuoka, Not set
The Cancer Institute Hospital of JFCR, Tokyo, Not set
Wakayama Medical University Hospital, Wakayama, Not set
National Cancer Center, Goyang-Si, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
University Malaya Medical Centre, Kuala Lumpur, Not set
Hospital Tengku Ampuan Afzan, Kuantan, Not set
Hospital Umum Sarawak, Kuching, Not set
Beacon Hospital Sdn Bhd, Petaling Jaya, Not set
Hosp Univ A Coruna, A Coruña, Not set
General University Hospital of Alicantet, Alacant, Not set
Hosp. Del Mar, Barcelona, Not set
Hosp. de La Santa Creu I Sant Pau, Barcelona, Not set
Hosp Univ Vall D Hebron, Barcelona, Not set
Inst. Cat. Doncologia-H Duran I Reynals, Barcelona, Not set
Hosp. Gral. Univ. Gregorio Maranon, Madrid, Not set
Hosp. Univ. Ramon Y Cajal, Madrid, Not set
Hosp. Univ. 12 de Octubre, Madrid, Not set
Hosp. Univ. La Paz, Madrid, Not set
Hosp Regional Univ de Malaga, Malaga, Not set
Hosp. Virgen Macarena, Sevilla, Not set
Hosp. Clinico Univ. de Valencia, Valencia, Not set
Hosp. Gral. Univ. Valencia, Valencia, Not set
Cheltenham General Hospital, Cheltenham, Not set
Torbay Hospital-Devon, Devon, Not set
Edinburgh Cancer Centre Western General, Edinburgh, Not set
Leicester Royal Infirmary, Leicester, Not set
University College London Hospitals, London, Not set
Nottingham City Hospital, Nottingham, Not set
Queen Alexandra Hospital, Portsmouth, Not set
Conditions: Carcinoma, Non-small-Cell Lung
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
Active Not Recruiting
The purpose of this study is to: (a) characterize the safety and tolerability of and to identify the recommended Phase 2 dose (RP2D) and schedule for erdafitinib in combination with cetrelimab, and for erdafitinib in combination with cetrelimab and platinum (cisplatin and carboplatin) chemotherapy and; (b) to evaluate the safety and clinical activity of erdafitinib alone and in combination with cetrelimab in cisplatin-ineligible participants with metastatic or locally advanced urothelial cancer... Read More
The purpose of this study is to: (a) characterize the safety and tolerability of and to identify the recommended Phase 2 dose (RP2D) and schedule for erdafitinib in combination with cetrelimab, and for erdafitinib in combination with cetrelimab and platinum (cisplatin and carboplatin) chemotherapy and; (b) to evaluate the safety and clinical activity of erdafitinib alone and in combination with cetrelimab in cisplatin-ineligible participants with metastatic or locally advanced urothelial cancer (UC) with select fibroblast growth factor receptor (FGFR) gene alterations and no prior systemic therapy for metastatic disease. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/17/2025
Locations: Rocky Mountain Cancer Centers, Aurora, Colorado +126 locations
Rocky Mountain Cancer Centers, Aurora, Colorado
Norton Cancer Institute, Louisville, Kentucky
Maryland Oncology Hematology, PA, Rockville, Maryland
Hackensack University Medical Center, Hackensack, New Jersey
Weill Cornell Medical College - NY Presbyterian Hospital, New York, New York
White Plains Hospital Center for Cancer Care, White Plains, New York
Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina
Toledo Clinic Cancer Centers, Toledo, Ohio
Penn State Hershey Cancer Institute, Hershey, Pennsylvania
Texas Oncology, P.A., Fort Worth, Texas
The University of Texas MD Anderson Cancer Center, Houston, Texas
Virginia Oncology Associates, Norfolk, Virginia
Brest Regional Oncology Dispensary, Brest, Not set
Gomel Regional Clinical Oncology Dispensary, Gomel, Not set
Grodno University Hospital, Grodno, Not set
State Institution N.N. Alexandrov Republican Scientific and, Lesnoy, Not set
Minsk city Clinical Oncological Dispensary, Minsk, Not set
Mogilev Regional Hospital, Mogilev, Not set
Vitebsk Regional Clinical Hospital, Vitebsk, Not set
ULB Hôpital Erasme, Bruxelles, Not set
Cliniques Universitaires Saint Luc, Bruxelles, Not set
Jolimont, Haine-Saint-Paul, Not set
Az Groeninge, Kortrijk, Not set
CHU de Liège - Domaine Universitaire du Sart Tilman, Liege, Not set
AZ Nikolaas - Campus Sint-Niklaas Moerland, Sint-Niklaas, Not set
GZA Ziekenhuizen- Campus St Augustinus, Wilrijk, Not set
Fundacao Pio XII, Barretos, Not set
Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, Not set
Liga Paranaense de Combate ao Cancer, Curitiba, Not set
Oncocentro Servicos Medicos e Hospitalares Ltda - Oncocentro, Fortaleza, Not set
Oncoclinicas Rio de Janeiro S A, Rio de Janeiro, Not set
Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), Rio de Janeiro, Not set
CEPHO Centro de Estudos e Pesquisa de Hematologia e Oncologia, Santo Andre, Not set
Institut de Cancerologie de Ouest (ICO) Site Paul Papin, Angers Cedex 02, Not set
Hopital Saint André, Bordeaux, Not set
Centre Francois Baclesse, Caen, Not set
Centre hospitalier Saint Louis, La Rochelle Cedex 1, Not set
Centre Leon Berard, Lyon, Not set
APHM Hopital Timone, Marseille, Not set
Hopital Europeen Georges Pompidou, Paris, Not set
Clinique Sainte Anne, Strasbourg, Not set
CHRU de Tours, Tours, Not set
Institut de Cancerologie de Lorraine, Vandoeuvre lès Nancy, Not set
Institut Gustave Roussy, Villejuif, Not set
Cliniche Humanitas Gavazzeni, Bergamo, Not set
Istituto di Candiolo, IRCCS, Candiolo, Not set
Ospedale Di Zona B Ramazzini, Carpi, Not set
UOS Oncologia Medica, A.O. Cannizzaro, Catania, Not set
Arcispedale S. Anna Ferrara, Ferrara, Not set
PO A.Manzoni di Lecco, ASST Lecco - Oncologia Medica - Lecco, Lecco, Not set
Ospedale Civile Di Livorno, Livorno, Not set
IRCCS Ospedale San Raffaele, Milano, Not set
ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set
Ospedale S. Maria Della Misericordia Centro Operativo Studi Clinici SC Oncologia Medica, Perugia, Not set
AUSL DI PIACENZA - Ospedale Guglielmo da Saliceto, Piacenza, Not set
Campus Bio Medico di Roma, Roma, Not set
Azienda Socio Sanitaria Territoriale (ASST) della Valtellin, Sondrio, Not set
Azienda Ospedaliera S. Maria Terni, Terni, Not set
Azienda Ospedaliero Universitaria S.Maria Della Misericordia, Udine, Not set
Chungnam National University Hospital, Daejeon, Not set
Chonnam National University Hospital, Gwangju, Not set
The Catholic university of Korea, St. Vincent's Hospital, Gyeonggi-do, Not set
Seoul National University Hospital, Seoul, Not set
Kangbuk Samsung Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
The Catholic University of Korea Seoul St Marys Hospital, Seoul, Not set
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Not set
Pusan National University Yangsan Hospital, Yangsan-si, Not set
Przychodnia Lekarska KOMED Roman Karaszewski, Konin, Not set
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im M Kopernika w Lodzi, Lodz, Not set
LUX MED Onkologia Sp. z o.o., Warszawa, Not set
Centralny Szpital Kliniczny MSWiA w Warszawie, Warszawa, Not set
Altai Regional Oncology Dispensary, Barnaul, Not set
Ivanovo Regional Oncology Dispensary, Ivanovo, Not set
GUZ Kursk Regional Oncology Dispensary, Kislino Village, Not set
Leningrad Regional Oncology Dispensary, Kuzmolovsky, Not set
City Clinical Hospital n.a. D.D.Pletnev, Moscow, Not set
Russian Scientific Center of Roentgenoradiology, Moscow, Not set
Moscow City Clinical Hospital # 62, Moscow, Not set
Clinical Diagnostic Centre of Nizhny Novgorod Region, Nizhny Novgorod, Not set
Privolzhsky District Medical Centre, Nizhny Novgorod, Not set
Clinical Oncology Dispensary, Omsk, Not set
LLC Novaya Clinica, Pyatigorsk, Not set
Private Medical Institution Euromedservice, Saint Petersburg, Not set
Russian Scientific Center of Radiology and Surgical Technologies, Sankt-Peterburg, Not set
Tambov Regional Oncology Clinical Dispansary, Tambov, Not set
Multifunctional clinical medical center 'Medical city', Tyumen, Not set
Hosp. Del Mar, Barcelona, Not set
Hosp Clinic de Barcelona, Barcelona, Not set
Hosp. Univ. Ramon Y Cajal, Madrid, Not set
Hosp. Clinico San Carlos, Madrid, Not set
Hosp Univ Fund Jimenez Diaz, Madrid, Not set
Hosp Univ Hm Sanchinarro, Madrid, Not set
Hosp Virgen de La Victoria, Málaga, Not set
Complexo Hosp. Univ. de Ourense, Ourense, Not set
Complejo Hospitalario de Vigo, Pontevedra, Not set
Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcon, Not set
Corporacio Sanitari Parc Tauli, Sabadell, Not set
Hosp. Univ. Marques de Valdecilla, Santander, Not set
H. Clinico Universitario de Santiago de Compostela, Santiago de Compostela, Not set
Hosp. Virgen Macarena, Sevilla, Not set
Hosp. Virgen Del Rocio, Sevilla, Not set
Instituto Valenciano de Oncologia, Valencia, Not set
Hosp. Clinico Univ. de Valencia, Valencia, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Not set
Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung, Not set
China Medical University Hospital, Taichung City, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei City, Not set
Chang-Gung Memorial Hospital, LinKou Branch, Taoyuan, Not set
Adana Acibadem Hospital, Adana, Not set
Memorial Ankara Hastanesi, Ankara, Not set
Hacettepe University Medical Faculty, Ankara, Not set
Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Not set
Adnan Menderes University Training and Research Hospital, Aydin, Not set
Trakya University Medical Faculty, Edirne, Not set
Istanbul University Cerrahpasa Medical Faculty, Istanbul, Not set
Istanbul Medeniyet University Goztepe Training and Research Hospital, Istanbul, Not set
Ege University, Izmir, Not set
Kocaeli University Medical Faculty, Kocaeli, Not set
Necmettin Erbakan University Meram Medical Faculty, Konya, Not set
Karadeniz Teknik University Medical Faculty, Trabzon, Not set
Royal Lancaster Infirmary, Lancaster, Not set
St Bartholomew's Hospital, London, Not set
University College London Hospitals Nhs Foundation Trust, London, Not set
Nottingham University Hospitals NHS Trust, Nottingham, Not set
Conditions: Urothelial Carcinoma
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recruiting
This study will assess the effect of Dato-DXd in combination with osimertinib or Dato-DXd monotherapy versus platinum-based doublet chemotherapy in terms of progression-free survival (PFS).
This study will assess the effect of Dato-DXd in combination with osimertinib or Dato-DXd monotherapy versus platinum-based doublet chemotherapy in terms of progression-free survival (PFS). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/15/2025
Locations: Research Site, Fayetteville, Arkansas +287 locations
Research Site, Fayetteville, Arkansas
Research Site, Duarte, California
Research Site, Fountain Valley, California
Research Site, La Jolla, California
Research Site, Los Angeles, California
Research Site, San Diego, California
Research Site, Fort Collins, Colorado
Research Site, Jacksonville, Florida
Research Site, Athens, Georgia
Research Site, Chicago, Illinois
Research Site, Evanston, Illinois
Research Site, Baltimore, Maryland
Research Site, Bethesda, Maryland
Research Site, Boston, Massachusetts
Research Site, Boston, Massachusetts
Research Site, Detroit, Michigan
Research Site, Omaha, Nebraska
Research Site, Morristown, New Jersey
Research Site, Northfield, New Jersey
Research Site, Bronx, New York
Research Site, New York, New York
Research Site, New York, New York
Research Site, Philadelphia, Pennsylvania
Research Site, Pittsburgh, Pennsylvania
Research Site, Chattanooga, Tennessee
Research Site, Nashville, Tennessee
Research Site, Fairfax, Virginia
Research Site, Fitzroy, Not set
Research Site, Heidelberg, Not set
Research Site, Kogarah, Not set
Research Site, Liverpool, Not set
Research Site, Nedlands, Not set
Research Site, Port Macquarie, Not set
Research Site, St Leonards, Not set
Research Site, Westmead, Not set
Research Site, Woodville, Not set
Research Site, Woolloongabba, Not set
Research Site, Charleroi, Not set
Research Site, Edegem, Not set
Research Site, Gent, Not set
Research Site, Ghent, Not set
Research Site, Hasselt, Not set
Research Site, Jette, Not set
Research Site, La Louvière, Not set
Research Site, Leuven, Not set
Research Site, Namur, Not set
Research Site, Roeselare, Not set
Research Site, Barretos, Not set
Research Site, Betim, Not set
Research Site, Blumenau, Not set
Research Site, Florianópolis, Not set
Research Site, Itajai, Not set
Research Site, Pelotas, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Sao Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Brampton, Ontario
Research Site, Newmarket, Ontario
Research Site, Toronto, Ontario
Research Site, Toronto, Ontario
Research Site, Montreal, Quebec
Research Site, Quebec, Not set
Research Site, Baoding, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Bengbu, Not set
Research Site, Changchun, Not set
Research Site, Changchun, Not set
Research Site, Changsha, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Deyang, Not set
Research Site, Ganzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hefei, Not set
Research Site, Hengyang, Not set
Research Site, Huaian, Not set
Research Site, Jinan, Not set
Research Site, Linyi, Not set
Research Site, Luoyang, Not set
Research Site, Luzhou, Not set
Research Site, Nanchang, Not set
Research Site, Nanjing, Not set
Research Site, Shanghai, Not set
Research Site, Shantou, Not set
Research Site, Shenyang, Not set
Research Site, Shenyang, Not set
Research Site, Tianjin, Not set
Research Site, Tianjin, Not set
Research Site, Weifang, Not set
Research Site, Wuhan, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, ANGERS Cedex 9, Not set
Research Site, Avignon, Not set
Research Site, Bordeaux, Not set
Research Site, Caen, Not set
Research Site, Lille Cedex, Not set
Research Site, Montpellier, Not set
Research Site, Nantes, Not set
Research Site, Paris Cedex 14, Not set
Research Site, Paris, Not set
Research Site, Pessac, Not set
Research Site, Quimper, Not set
Research Site, Toulon Armees, Not set
Research Site, Toulouse Cedex 9, Not set
Research Site, Villejuif Cedex, Not set
Research Site, Berlin-Zehlendorf, Not set
Research Site, Berlin, Not set
Research Site, Bonn, Not set
Research Site, Essen, Not set
Research Site, Georgsmarienhuette, Not set
Research Site, Großhansdorf, Not set
Research Site, Hamburg, Not set
Research Site, Hamburg, Not set
Research Site, Heidelberg, Not set
Research Site, Kempten, Not set
Research Site, Löwenstein, Not set
Research Site, Nürnberg, Not set
Research Site, Oldenburg, Not set
Research Site, Athens, Not set
Research Site, Athens, Not set
Research Site, Athens, Not set
Research Site, Athens, Not set
Research Site, Heraklion, Not set
Research Site, Thessaloniki, Not set
Research Site, Thessaloniki, Not set
Research Site, Thessaloniki, Not set
Research Site, Thessaloniki, Not set
Research Site, Hong Kong, Not set
Research Site, Hong Kong, Not set
Research Site, Shatin, Not set
Research Site, Amravati, Not set
Research Site, Bhubaneswar, Not set
Research Site, Hyderabad, Not set
Research Site, Kolhapur, Not set
Research Site, Mumbai, Not set
Research Site, Mysuru, Not set
Research Site, Namakkal, Not set
Research Site, Pune, Not set
Research Site, Raipur, Not set
Research Site, Rajasthan, Not set
Research Site, Ranchi, Not set
Research Site, Thane, Not set
Research Site, Trivandrum, Not set
Research Site, Varanasi, Not set
Research Site, Beer Sheva, Not set
Research Site, Haifa, Not set
Research Site, Haifa, Not set
Research Site, Jerusalem, Not set
Research Site, Jerusalem, Not set
Research Site, Kfar-Saba, Not set
Research Site, Petach Tikva, Not set
Research Site, Ramat Gan, Not set
Research Site, Tel Aviv, Not set
Research Site, Bari, Not set
Research Site, Milano, Not set
Research Site, Misterbianco, Not set
Research Site, Monza, Not set
Research Site, Napoli, Not set
Research Site, Orbassano, Not set
Research Site, Padova, Not set
Research Site, Parma, Not set
Research Site, Perugia, Not set
Research Site, Roma, Not set
Research Site, Rozzano, Not set
Research Site, Verona, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Iruma-Gun, Not set
Research Site, Iwakuni-shi, Not set
Research Site, Kobe, Not set
Research Site, Koto-ku, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Matsuyama-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Niigata-shi, Not set
Research Site, Osaka-Sayama, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Sunto-gun, Not set
Research Site, Toyoake-shi, Not set
Research Site, Utsunomiya-shi, Not set
Research Site, Wakayama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Busan, Not set
Research Site, Chungcheongbuk-do, Not set
Research Site, Goyang-si, Not set
Research Site, Gyeonggi-do, Not set
Research Site, Jinju-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Alor Setar, Not set
Research Site, Cheras, Not set
Research Site, Johor Bahru, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuching, Not set
Research Site, Perai, Not set
Research Site, Petaling Jaya, Not set
Research Site, Selangor, Not set
Research Site, Amersfoort, Not set
Research Site, Harderwijk, Not set
Research Site, Rotterdam, Not set
Research Site, Zutphen, Not set
Research Site, Bacolod, Not set
Research Site, Cebu City, Not set
Research Site, Davao City, Not set
Research Site, Manila, Not set
Research Site, Quezon, Not set
Research Site, Quezon, Not set
Research Site, San Juan, Not set
Research Site, Katowice, Not set
Research Site, Krakow, Not set
Research Site, Olsztyn, Not set
Research Site, Poznan, Not set
Research Site, Łódź, Not set
Research Site, Braga, Not set
Research Site, Porto, Not set
Research Site, Porto, Not set
Research Site, Craiova, Not set
Research Site, Craiova, Not set
Research Site, Singapore, Not set
Research Site, Singapore, Not set
Research Site, Singapore, Not set
Research Site, Barakaldo, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, El Palmar, Not set
Research Site, L'Hospitalet de Llobregat, Not set
Research Site, La Coruna, Not set
Research Site, Madrid, Not set
Research Site, Majadahonda, Not set
Research Site, Malaga, Not set
Research Site, Palma de Mallorca, Not set
Research Site, Pamplona, Not set
Research Site, Santander, Not set
Research Site, Santiago De Compostela-Coruña, Not set
Research Site, Sevilla, Not set
Research Site, Valencia, Not set
Research Site, Valencia, Not set
Research Site, Valladolid, Not set
Research Site, Changhua City, Not set
Research Site, Kaohsiung City, Not set
Research Site, New Taipei, Not set
Research Site, Taichung, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Tainan, Not set
Research Site, Taipei City, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Chiang Mai, Not set
Research Site, Hat Yai, Not set
Research Site, Khon-Kaen, Not set
Research Site, Pathumthani, Not set
Research Site, Birmingham, Not set
Research Site, Cambridge, Not set
Research Site, Glasgow, Not set
Research Site, Leicester, Not set
Research Site, London, Not set
Research Site, Manchester, Not set
Research Site, Middlesbrough, Not set
Research Site, Hanoi, Not set
Conditions: Metastatic Non-small Cell Lung Cancer
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
Completed
This randomized, double-blind, placebo-controlled, two-arm study will assess the safety and efficacy of pertuzumab in addition to chemotherapy plus trastuzumab as adjuvant therapy in participants with operable HER2-positive primary breast cancer. This study will be carried out in collaboration with the Breast International Group (BIG).
This randomized, double-blind, placebo-controlled, two-arm study will assess the safety and efficacy of pertuzumab in addition to chemotherapy plus trastuzumab as adjuvant therapy in participants with operable HER2-positive primary breast cancer. This study will be carried out in collaboration with the Breast International Group (BIG). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/11/2025
Locations: HonorHealth Research Institute ? Bisgrove, Scottsdale, Arizona +545 locations
HonorHealth Research Institute ? Bisgrove, Scottsdale, Arizona
Providence Regional Medical Center, Everett, California
Marin Cancer Care Inc, Greenbrae, California
Kaiser Permanente - Hayward, Hayward, California
UCSD Moores Cancer Center, La Jolla, California
Cedars-Sinai Medical Center, Los Angeles, California
Kaiser Permanente - Oakland, Oakland, California
Kaiser Permanente - Roseville, Roseville, California
Sutter Cancer Center, Sacramento, California
Kaiser Permanente Sacramento Medical Center, Sacramento, California
Southern California Kaiser Permanente, San Diego, California
K. Permanente - San Fransisco, San Francisco, California
K. Permanente - San Jose, San Jose, California
K. Permanente - Santa Clara, Santa Clara, California
K. Permanente - S. San Fran, South San Francisco, California
Kaiser Permanente, Vallejo, California
K. Permanente - Walnut Creek, Walnut Creek, California
Rocky Mountain Cancer Center - Denver, Denver, Colorado
Lutheran Hematology &Oncology, Wheat Ridge, Colorado
Eastern Ct Hema/Onco Assoc, Norwich, Connecticut
Washington Cancer Institute at MedStar Washington Hospital Center., Washington, District of Columbia
Georgetown U, Washington, District of Columbia
Florida Cancer Specialists, Fort Myers, Florida
Memorial Cancer Institute, Hollywood, Florida
Mayo Clinic-Jacksonville, Jacksonville, Florida
Cancer Specialists, Jacksonville, Florida
Ocala Oncology Center, Ocala, Florida
Memorial Breast Cancer Center, Pembroke Pines, Florida
Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie, Florida
Florida Cancer Specialists, Saint Petersburg, Florida
Florida Cancer Specialists, Research Department, West Palm Beach, Florida
Phoebe Putney Memorial Hospital, Albany, Georgia
Georgia Cancer Specialists, Atlanta, Georgia
Northwest Georgia Oncology Centers PC - Marietta, Marietta, Georgia
Kootenai Cancer Center, Post Falls, Idaho
Rush University Medical Center, Chicago, Illinois
Uni of Chicago, Chicago, Illinois
Ingalls Memorial Hospital, Harvey, Illinois
Loyola University Med Center, Maywood, Illinois
Edward Cancer Center Naperville, Naperville, Illinois
Illinois Cancer Care, Peoria, Illinois
Edward Cancer Center Plainfield, Plainfield, Illinois
Quincy Medical Group, Quincy, Illinois
Carle Foundation, Urbana, Illinois
University of Iowa, Iowa City, Iowa
Cancer Center of Kansas, Wichita, Kansas
Cancer Center of Acadiana at Lafayette General, Lafayette, Louisiana
Cancer Care of Maine, Bangor, Maine
New England Cancer Specialists, Scarborough, Maine
Mercy Medical Center, Baltimore, Maryland
Weinberg CA Inst Franklin Sq, Baltimore, Maryland
Maryland Oncology & Hematology, PA, Bethesda, Maryland
Massachusetts General Hospital., Boston, Massachusetts
Boston Medical Center, Boston, Massachusetts
Beth Israel Deac Med Ctr, Boston, Massachusetts
Dana Farber Can Ins, Boston, Massachusetts
Berkshire Hematology, Oncology Pc, Pittsfield, Massachusetts
Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan
West Michigan Cancer Center, Kalamazoo, Michigan
Southdale Cancer Clinic, Edina, Minnesota
Coborn Cancer Center, Saint Cloud, Minnesota
Metro-Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota
Jackson Oncology Associates, PLLC, Jackson, Mississippi
Washington University School of Medicine, Saint Louis, Missouri
Heartland CCOP/Missouri Baptist Medical Center, Saint Louis, Missouri
Cancer Alliance of Nebraska, Lincoln, Nebraska
Cancer Alliance of Nebraska, Omaha, Nebraska
Dartmouth Hitchcock Med Center, Lebanon, New Hampshire
Saint Barnabas Medical Center, Livingston, New Jersey
New York Oncology Hematology, P.C., Albany, New York
Montefiore Medical Center, Bronx, New York
Roswell Park Cancer Inst., Buffalo, New York
Mount Sinai Beth Israel Medical Center, New York, New York
Mount Sinai Beth Israel Comprehensive Cancer Center, New York, New York
Mount Sinai West, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
SUNY Upstate Medical University, Syracuse, New York
University of North Carolina-Chapel Hill, Chapel Hill, North Carolina
Carolina Oncology Specialists, PA - Hickory, Hickory, North Carolina
Oncology Hematology Care Inc, Cincinnati, Ohio
The Mark H. Zangmeister Ctr, Columbus, Ohio
Dayton Clinical Oncology Prog, Dayton, Ohio
Toledo Clinic Cancer Center, Toledo, Ohio
Northwest Cancer Specialists - Portland (NE Hoyt St), Portland, Oregon
Abramson Cancer Center, Philadelphia, Pennsylvania
Albert Einstein Healthcare Network, Philadelphia, Pennsylvania
Magee Womens Hospital, Pittsburgh, Pennsylvania
Charleston Oncology, P .A, Charleston, South Carolina
Roper Bon Secours St. Francis Cancer Center, Charleston, South Carolina
South Carolina Oncology Associates - SCRI, Columbia, South Carolina
University of Missouri-Columbia, Columbia, South Carolina
Cancer Centers of the Carolina, Greenville, South Carolina
Sanford USD School of Medicine, Sioux Falls, South Dakota
Tennessee Oncology , PLLC - Chattanooga, Chattanooga, Tennessee
Tennessee Oncology - Nashville, Nashville, Tennessee
Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee
Texas Oncology-Medical City Dallas, Dallas, Texas
Texas Oncology - DFW at Dallas Presbyterian Hospital, Dallas, Texas
Texas Oncology - DFW, Dallas, Texas
Texas Oncology-El Paso Cancer Treatment Center Grandview, El Paso, Texas
Texas Oncology - DFW Fort Worth, Fort Worth, Texas
The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth, Texas
Texas Oncology, P.A. - Garland, Garland, Texas
Texas Oncology - Houston (Gessner), Houston, Texas
Cancer Care Centers of South Texas-HOAST - San Antonio, New Braunfels, Texas
Texas Oncology - DFW Plano, Plano, Texas
Texas Oncology-Tyler, Tyler, Texas
Community Cancer Trials of Utah, Ogden, Utah
Wellmonth Physician Services, Bristol, Virginia
Virginia Cancer Institute, Richmond, Virginia
Providence St. Mary Regional Cancer Center, Walla Walla, Washington
West Virginia University Hospitals Inc, Morgantown, West Virginia
Green Bay Oncology/St. Mary?s Hospital, Green Bay, Wisconsin
Marshfield Clinic, Marshfield, Wisconsin
Centro Medico San Roque, San Miguel de Tucuman, Not set
Lismore Base Hospital, Lismore, New South Wales
Mater Misericordiae Hospital, Sydney, New South Wales
Newcastle Mater Misericordiae Hospital, Waratah, New South Wales
Westmead Hospital, Westmead, New South Wales
Wesley Medical Centre, Auchenflower, Queensland
Mater Hospital, Brisbane, Queensland
Royal Adelaide Hospital, Adelaide, South Australia
Royal Hobart Hospital, Hobart, Tasmania
Monash Medical Centre, EAST Bentleigh, Victoria
Geelong Hospital, Geelong, Victoria
Austin Hospital, Heidelberg, Victoria
Peter Maccallum Cancer Institute, Melbourne, Victoria
Sir Charles Gairdner Hospital, Perth, Western Australia
Lkh-Univ. Klinikum Graz, Graz, Not set
Tiroler Landeskrankenanstalten Ges.M.B.H., Innsbruck, Not set
Ordensklinikum Linz Barmherzige Schwestern, Linz, Not set
Lhk Feldkirch, Rankweil, Not set
Lkh Salzburg - Univ. Klinikum Salzburg, Salzburg, Not set
A. Ö. Krankenhaus Der Barmherzigen Brüder, St Veit An Der Glan, Not set
Lkh Vöcklabruck, Vöcklabruck, Not set
Klinikum Kreuzschwestern Wels, Wels, Not set
Medizinische Universität Wien; Klinik für Frauenheilkunde, Wien, Not set
Medizinische Universität Wien; Klinik für Innere Medizin; Abteilung für Onkologie, Wien, Not set
Krankenhaus Der Stadt Wien-Hietzing, Wien, Not set
Institut Jules Bordet, Anderlecht, Not set
GHdC Site Les Viviers, Charleroi, Not set
UZ Antwerpen, Edegem, Not set
Jessa Zkh (Campus Virga Jesse), Hasselt, Not set
AZ Groeninge, Kortrijk, Not set
UZ Leuven Gasthuisberg, Leuven, Not set
CHU de Liège (Sart Tilman), Liege, Not set
Clinique Ste-Elisabeth, Namur, Not set
Sint Augustinus Wilrijk, Wilrijk, Not set
UMHAT Tsaritsa Yoanna - ISUL, Sofia, Not set
SHATO - Sofia, Sofia, Not set
SHATOD Dr. Marko Antonov Markov-Varna, EOOD, Varna, Not set
Arthur J.E. Child Comprehensive Cancer Center, Calgary, Alberta
Cross Can Inst, Edmonton, Alberta
BC Cancer Agency, CSI, Kelowna, British Columbia
BC Cancer ? Surrey, Surrey, British Columbia
BCCA-Vancouver Cancer Centre, Vancouver, British Columbia
Bcca - Vancouver Island Cancer Centre, Victoria, British Columbia
CancerCare Manitoba, Winnipeg, Manitoba
Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia
Hamilton Health Sciences - Juravinski Cancer Centre, Hamilton, Ontario
Cancer Centre of Southeastern Ontario, Kingston, Ontario
London Health Sciences Centre, London, Ontario
Credit Valley Hospital/Carlo Fidani Peel Regional Cancer Centre, Mississauga, Ontario
Southlake Regional Health Center, Newmarket, Ontario
Ottawa Regional Cancer Centre, Ottawa, Ontario
Niagara Health Systems - St. Catherines General Site, St. Catharines, Ontario
Northeastern Ontario, Sudbury, Ontario
Sunnybrook Odette Cancer Centre, Toronto, Ontario
Mount Sinai Hospital, Toronto, Ontario
Princess Margaret Cancer Center, Toronto, Ontario
Hopital Maisonneuve- Rosemont, Montreal, Quebec
Hopital Sacre-Coeur Research Centre, Montreal, Quebec
Allan Blair Cancer Centre, Regina, Saskatchewan
Hopital du Saint Sacrement, Quebec, Not set
INTOP, Providencia, Not set
Fundacion Arturo Lopez Perez, Santiago, Not set
Cancer Hospital Chinese Academy of Medical Sciences., Beijing, Not set
The Affiliated Hospital of Military Medical Sciences(The 307th Hospital of Chinese PLA), Beijing, Not set
Hu Nan Provincial Cancer Hospital, Chang Sha, Not set
Jilin Cancer Hospital, Changchun, Not set
the First Hospital of Jilin University, Changchun, Not set
Sichuan Provincial People's Hospital, Chengdu, Not set
Fujian Medical University Union Hospital, Fujian, Not set
The 900th Hospital of PLA joint service support force, Fuzhou, Not set
Sun Yet-sen University Cancer Center, Guangzhou, Not set
Guangdong General Hospital, Guangzhou, Not set
The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Not set
Harbin Medical University Cancer Hospital; Dept. of Breast Surgery, Harbin, Not set
Harbin Medical University Cancer Hospital, Harbin, Not set
The 1st Affiliated Hospital of Nanchang Unversity, Nanchang, Not set
Shanghai Jiao Tong University School of Medicine (SJTUSM) - Ruijin Hospital (GuangCi Hospital), Shanghai, Not set
Fudan University Shanghai Cancer Center, Shanghai, Not set
Shanghai First People's Hospital, Shanghai, Not set
Changhai Hospital of Shanghai, Shanghai, Not set
Hebei Medical University Fourth Hospital, Shijiazhuang, Not set
Xiehe Hospital, Tongji Medical College Huazhong University of Science & Technology, Wuhan, Not set
Tongji Hosp, Tongji Med. Col, Huazhong Univ. of Sci. & Tech, Wuhan, Not set
Hubei Cancer Hospital, Wuhan, Not set
Fundacion Cardioinfantil, Bogota, Not set
Inst. Nacional de Cancerologia, Bogota, Not set
Hospital Pablo Tobon Uribe, Medellin-Antioquia, Not set
Oncomedica S.A., Monteria, Not set
Uni Hospital Split, Split, Not set
General Hospital Varazdin, Varazdin, Not set
Clinical Hospital Centre Zagreb, Zagreb, Not set
Masarykuv onkologicky ustav, Brno, Not set
Fakultni Nemocnice Hradec Kralove, Hradec Kralove, Not set
Fakultni nemocnice Olomouc, Olomouc, Not set
MULTISCAN, s.r.o., Radiologicke centrum Pardubice, Pardubice, Not set
Aalborg Universitetshospital, Aalborg, Not set
Sydvestjysk Sygehus Esbjerg, Esbjerg, Not set
Herlev Hospital, Herlev, Not set
Nordsjællands Hospital, Hillerød, Onkologisk Afdeling, Hillerod, Not set
Rigshospitalet, København, Not set
Sjællands Universitetshospital, Næstved, Naestved, Not set
Odense Universitetshospital, Onkologisk Afdeling R, Odense C, Not set
Sygehus Syd Roskilde, Roskilde, Not set
Vejle Sygehus, Vejle, Not set
Hospital Oncologia, El Salvador, Not set
Clinique De L Europe, Amiens, Not set
ICO Paul Papin, Angers, Not set
HOP Prive Arras Les Bonnettes, Arras, Not set
Institut Sainte Catherine, Avignon, Not set
ICONE, Bezannes, Not set
Institut Bergonie, Bordeaux, Not set
Polyclinique Bordeaux Nord, Bordeaux, Not set
Hopital Augustin Morvan, Brest, Not set
Centre Francois Baclesse, Caen, Not set
Centre Jean Perrin, Clermont-ferrand, Not set
Centre Leonard De Vinci, Dechy, Not set
Centre Georges-François Lecler, Dijon, Not set
Institut Daniel Hollard, Grenoble, Not set
Centre Hospitalier Departemental Les Oudairies, La Roche Sur Yon, Not set
Clinique des Ormeaux, Le Havre, Not set
Centre Oscar Lambret, Lille, Not set
Hopital Dupuytren, Limoges, Not set
Centre Leon Berard, Lyon, Not set
Institut Paoli Calmettes, Marseille, Not set
Institut régional du Cancer Montpellier, Montpellier, Not set
Polyclinique De Gentilly, Nancy, Not set
Centre Antoine Lacassagne, Nice, Not set
Institut de cancerologie du Gard, Nimes, Not set
Institut Curie, Paris, Not set
Ch Pitie Salpetriere, Paris, Not set
Polyclinique Francheville, Perigueux, Not set
Clinique Armoricaine Radiologie, Plerin, Not set
Chu De Poitiers, Poitiers, Not set
Institut Jean Godinot, Reims, Not set
Centre Eugene Marquis, Rennes, Not set
Centre Henri Becquerel, Rouen, Not set
ICL, Saint Prient En Jarez, Not set
Centre Rene Huguenin, St Cloud, Not set
Ico Rene Gauducheau, St Herblain, Not set
Institut d'oncologie de l'Orangerie, Strasbourg, Not set
Hopital Hautepierre, Strasbourg, Not set
Institut Claudius Regaud, Toulouse, Not set
Clinique Pasteur, Toulouse, Not set
Centre Alexis Vautrin, Vandoeuvre Les Nancy, Not set
Institut Gustave Roussy, Villejuif, Not set
Gesundheitszentrum St. Marien GmbH, Amberg, Not set
Hochwaldkrankenhaus, Bad Nauheim, Not set
Praxisklinik Krebsheilkunde für Frauen / Brustzentrum (Dres. Kittel/Klare), Berlin-Lichtenberg, Not set
Praxis Dr. Schoenegg, Berlin, Not set
HELIOS Klinikum Berlin-Buch, Berlin, Not set
Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche, Berlin, Not set
Onkologische Schwerpunktpraxis Bielefeld, Bielefeld, Not set
Universitätsklinikum Bonn, Bonn, Not set
Praxis Dr. Ralf Lorenz, Braunschweig, Not set
Hämato-Onkologie im Medicum/Home, Bremen, Not set
Klinikum Sindelfingen-Böblingen, Böblingen, Not set
Klinikum Chemnitz gGmbH, Chemnitz, Not set
DONAU ISAR Klinikum Deggendorf, Deggendorf, Not set
St. Johannes-Hospital, Dortmund, Not set
Universitätsklinikum "Carl Gustav Carus", Dresden, Not set
Universitätsklinikum Düsseldorf, Düsseldorf, Not set
Luisenkrankenhaus GmbH & Co. KG., Brustzentrum, Düsseldorf, Not set
Praxis für Hamatologie und Onkologie, Erfurt, Not set
Universitätsklinikum Erlangen, Erlangen, Not set
Klinikum Esslingen, Esslingen, Not set
Hämatologisch-Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus, Frankfurt am Main, Not set
Klinik Johann Wolfgang von Goethe Uni, Frankfurt, Not set
Städtische Kliniken Frankfurt am Main Höchst, Frankfurt, Not set
Praxis für Interdisziplinäre Onkologie und Hämatologie GbR, Freiburg, Not set
Dres.Jochen Wilke und Harald Wagner, Fürth, Not set
Universitätsklinikum Greifswald, Greifswald, Not set
Universitätsklinikum Halle (Saale), Halle, Not set
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Not set
SANA Klinikum Hameln-Pyrmont, Hameln, Not set
Diakovere Henriettenstift, Frauenklinik, Hannover, Not set
MVZ Onko Medical GmbH Hannover, Ralf Lohse (Geschäftsführer), Hannover, Not set
Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, Not set
Praxisgemeinschaft, Hildesheim, Not set
Universitätsklinikum des Saarlandes, Homburg/Saar, Not set
ViDia Christliche Kliniken Karlsruhe, Vincentius-Diakonissen-Kliniken gAG, Karlsruhe, Not set
Elisabeth-Krankenhaus Brustzentrum, Kassel, Not set
Klinikum Kassel GmbH, Kassel, Not set
UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe, Kiel, Not set
St. Elisabeth Krankenhaus Köln GmbH, Koeln, Not set
Uniklinik Köln, Klinik und Poliklinik und Geburtshilfe, Köln, Not set
Klinikum Landshut Frauenklinik, Landshut, Not set
Sankt Elisabeth Krankenhaus, Leipzig, Not set
Evangelisches Krankenhaus, Ludwigsfelde, Not set
Universitätsklinikum Schleswig-Holstein / Campus Lübeck, Lübeck, Not set
Universitätsmedizin Mainz, Mainz, Not set
Rotkreuzklinikum München, Muenchen, Not set
Brustzentrum Rhein-Ruhr Servicegesellschaft mbH, Mönchengladbach, Not set
Klinikum der Universität München, München, Not set
Klinikum rechts der Isar der TU München, München, Not set
Universitätsklinikum Münster, Münster, Not set
Sana Klinikum Offenbach GmbH, Offenbach, Not set
Medizinisches Versorgungszentrum am Klinikum Oldenburg GmbH, Oldenburg, Not set
Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum, Ravensburg, Not set
Oncologianova GmbH, Recklinghausen, Not set
RoMed Klinikum Rosenheim, Rosenheim, Not set
Universitätsfrauen- und Poliklinik am Klinikum Suedstadt, Rostock, Not set
MVZ für Hämatologie, Onkologie, Strahlentherapie und Palliativmedizin -, Stade, Not set
Klinikum Mutterhaus der Borromaeerinnen gGmbH, Trier, Not set
Universitätsklinik Tübingen, Tübingen, Not set
Universitätsklinikum Ulm Am Michelsberg, Ulm, Not set
Dres. Arnd Nusch Naser Ali-Mohammad Kalhori und Werner Langer, Velbert, Not set
Schwarzwald-Baar Klinikum Klinik für Frauenheilkunde und Geburtshilfe, Villingen-Schwenningen, Not set
St. Josefs-Hospital Wiesbaden, Wiesbaden, Not set
Marien-Hospital Witten, Witten, Not set
Hämatologisch-Onkologische Schwerpunktpraxis Dres. Schlag & Schöttker, Würzburg, Not set
Grupo Angeles, Guatemala City, Not set
Queen Mary Hospital; Dept. of Clinical Oncology, Hong Kong, Not set
Queen Mary Hospital; Surgery, Hong Kong, Not set
Orszagos Onkologiai Intezet, Budapest, Not set
Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Not set
Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika, Debrecen, Not set
Petz Aladar Megyei Oktato Korhaz, Gyor, Not set
Békés Megyei Pándy Kálmán Kórház, Gyula, Not set
Bács-Kiskun Vármegyei Oktatókórház, Kecskemet, Not set
Szegedi Tudomanyegyetem, AOK, Szent-Gyorgyi Albert Klinikai Kozpont, Onkoterapias Klinika, Szeged, Not set
Cork Uni Hospital, Cork, Not set
Mater Misericordiae Uni Hospital, Dublin, Not set
St. James Hospital, Dublin, Not set
Beaumont Hospital, Dublin, Not set
St Vincent'S Uni Hospital, Dublin, Not set
Galway University Hospital, Galway, Not set
University Hospital Limerick - Oncology, Limerick, Not set
Rambam Medical Center, Haifa, Not set
Rabin MC, Petach Tikva, Not set
Chaim Sheba Medical Center, Ramat-Gan, Not set
Kaplan Medical Center, Rehovot, Not set
Sourasky / Ichilov Hospital, Tel Aviv, Not set
Campus Universitario S.Venuta, Catanzaro, Calabria
AORN'S.G.Moscati, Avellino, Campania
IRCCS Istituto Nazionale Tumori Fondazione Pascale, Napoli, Campania
Ist. Uni Federico Ii, Napoli, Campania
Azienda Ospedaliero-Universitaria S.Orsola-Malpighi, Bologna, Emilia-Romagna
Ospedale Ramazzini, Carpi, Emilia-Romagna
Arcispedale Santa Maria Nuova, Reggio Emilia, Emilia-Romagna
Irccs Centro Di Riferimento Oncologico (CRO), Aviano, Friuli-Venezia Giulia
Divisione Onc Med dell'Azienda, Udine, Friuli-Venezia Giulia
Ospedale Belcolle Di Viterbo, Viterbo, Lazio
Ente Ospedaliero Ospedali Galliera, Genova, Liguria
Az. Osp. Uni Ria San Martino, Genova, Liguria
IRCCS Istituto Nazionale Per La Ricerca Sul Cancro (IST), Genova, Liguria
Asst Degli Spedali Civili Di Brescia, Brescia, Lombardia
Asst Di Lecco, Lecco, Lombardia
Ospedale Mater Salutis, Legnago, Lombardia
Irccs Istituto Europeo Di Oncologia (IEO), Milano, Lombardia
Policlinico di Monza, Monza, Lombardia
IRCCS Fondazione Maugeri, Pavia, Lombardia
IRCCS Istituto Clinico Humanitas, Rozzano, Lombardia
Az. Osp. Di Busto P.O. Di Saronno, Saronno, Lombardia
Ospedale S. Croce Di Fano, Fano, Marche
Fondazione Del Piemonte Per L'oncologia Ircc Di Candiolo, Candiolo, Piemonte
Ospedale Antonio Perrino, Brindisi, Puglia
Nuovo Ospedale di Prato S. Stefano - Azienda USL Toscana Centro, Prato, Toscana
Ospedale Di Bolzano, Bolzano, Trentino-Alto Adige
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia, Perugia, Umbria
Azienda Ospedaliera S. Maria - Terni, Terni, Umbria
Aichi Cancer Center Hospital, Breast Oncology, Aichi, Not set
Chiba Cancer Center, Chiba, Not set
National Cancer Center Hospital East, Chiba, Not set
Natl Hosp Org Shikoku, Ehime, Not set
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
Gunma University Hospital, Gunma, Not set
Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Not set
Iwate Med Univ School of Med, Iwate, Not set
Sagara Hospital, Kagoshima, Not set
St. Marianna University School of Medicine Hospital, Breast and Endocrine Surgery, Kanagawa, Not set
Tokai University Hospital, Breast Surgery, Kanagawa, Not set
Kumamoto Shinto General Hospital, Kumamoto, Not set
Kyoto University Hospital, Kyoto, Not set
Niigata Cancer Ctr Hospital, Niigata, Not set
National Hospital Organization Osaka National Hospital, Osaka, Not set
Osaka International Cancer Institute, Osaka, Not set
Saitama Medical University International Medical Center, Saitama, Not set
Saitama Cancer Center, Breast Oncology, Saitama, Not set
Shizuoka Cancer Center, Shizuoka, Not set
Shizuoka General Hospital, Shizuoka, Not set
Jichi Medical School, Tochigi, Not set
National Cancer Center Hospital, Tokyo, Not set
Tokyo Metropolitan, Tokyo, Not set
The Cancer Inst. Hosp. of JFCR, Tokyo, Not set
Tokyo Medical Uni. Hospital, Tokyo, Not set
Seoul National University Bundang Hospital, Gyeonggi-do, Not set
Seoul National Uni Hospital, Seoul, Not set
Yonsei University Severance Hospital, Seoul, Not set
Kyunghee University Hospital, Seoul, Not set
Samsung Medical Centre, Seoul, Not set
Korea University Anam Hospital, Seoul, Not set
Centro Estatal de Oncología de Campeche, Campehe, Campeche
Fundacion Rodolfo Padilla Padilla A.C., León, Guanajuato
Núcleo de Especialidades Oncológicas, Guadalajara, Jalisco
Hospital Angeles Metropolitano, Mexico City, Mexico CITY (federal District)
Hospital General de México, Mexico DF, Mexico CITY (federal District)
Centro Universitario Contra El Cancer, Monterrey, Nuevo LEON
Centro de Diagnóstico y Tratamiento Integral de Mama, Hospital San José Tec de Monterrey, Montrrey, Nuevo LEON
Oaxaca Site Management Organization, Oaxaca de Juárez, Oaxaca
Médicos Especialistas en Cáncer SC, Aguascalientes, Not set
Centro Estatal De Cancerologia De Durango, Durango, Not set
Cancerologia de Queretaro, Queretaro, Not set
Medisch Centrum Alkmaar, Alkmaar, Not set
Amphia ziekenhuis, locatie langendijk, Breda, Not set
Reinier de Graaf Gasthuis, Delft, Not set
Academish Ziekenhuis Maastricht (Azm), Maastricht, Not set
Isala Klinieken, Zwolle, Not set
Waikato Hospital, Hamilton, Not set
Palmerston North Hospital, Palmerston North, Not set
The Panama Clinic, Panama City, Not set
Centro Oncologico America, Panama, Not set
Instituto Nacional de Enfermedades Neoplasicas, Lima, Not set
Clinica Anglo Americana - Centro de Investigacion Oncologia CAA, Lima, Not set
Clinica El Golf, San Isidro, Not set
Clinica Peruana Americana, Trujillo, Not set
University Of Santo Tomas, Manila, Not set
Rizal Medical Center, Pasig City, Not set
Veterans Memorial Medical Ctr, Quezon City, Luzon, Not set
Bialostockie Ctr Onkologii, Bialystok, Not set
Centrum Onkologii, Bydgoszcz, Not set
Uniwersyteckie Centrum Kliniczne, Klinika Onkologii i Radioterapii, Gda?sk, Not set
Opolskie Centrum Onkologii, Opole, Not set
Narodowy Inst.Onkologii im.Sklodowskiej-Curie Panstw.Inst.Bad, Warszawa, Not set
NZOZ Mazowiecki Szpital Onkologiczny Uczelni Warszawskiej im. M. Sk?odowskiej-Curie, Wieliszew, Not set
Emergency University Bucharest Hospital, Bucharest, Not set
Prof. Dr. I. Chiricuta Institute of Oncology, Cluj Napoca, Not set
Oncology Inst. Cluj-Napoca, Cluj-napoca, Not set
Euroclinic Center of Oncology SRL, Iasi, Not set
S.I. Russian Oncological Research Center n.a. N.N. Blokhin, Moscow, Moskovskaja Oblast
State Budget Institution of Healthcare of Stavropol region Pyatigorsk Oncology Dispensary, Pyatigorsk, Stavropol
Clinical Oncology Dispensary of Ministry of Health of Tatarstan, Kazan, Tatarstan
SBI of Healthcare Samara Regional Clinical Oncology Dispensary, Samara, Not set
SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary, Stavropol, Not set
Tula Regional Oncology Dispensary, Tula, Not set
Institute of Oncology Ljubljana, Ljubljana, Not set
National Hospital, Bloemfontein, Not set
Wits Donald Gordon Clinical Trial Centre, Johannesburg, Not set
Steve Biko Academic Hospital, Pretoria, Not set
Hospital General Universitario de Elche, Elche, Alicante
Corporacio Sanitaria Parc Tauli, Sabadell, Barcelona, Barcelona
Hospital Universitario Marques de Valdecilla, Santander, Cantabria
Hospital Universitario Reina Sofia, Córdoba, Cordoba
IInstituto Oncologico de San Sebastian, Oncologikoa, San Sebastian, Guipuzcoa
Hospital de Donostia, San Sebastian, Guipuzcoa
Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares
Hospital Son Llatzer, Palma de Mallorca, Islas Baleares
Complejo Hospitalario Universitario A Coruña (CHUAC, Materno Infantil), Oncología, La Coruña, LA Coruna
Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, LA Coruna
Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Lerida
Hospital Clinico Universitario Virgen de la Victoria, Málaga, Malaga
Hospital Universitario de Canarias, La Laguna, Tenerife
Hospital del Mar, Barcelona, Not set
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Not set
Hospital Clínic i Provincial, Barcelona, Not set
Hospital de la Santa Creu i Sant Pau, Barcelona, Not set
Hospital Duran i Reynals, Barcelona, Not set
Hospital Universitari Germans Trias i Pujol, Barcelona, Not set
Hospital Provincial de Castellon, Castellon, Not set
Hospital Juan Ramon Jimenez, Huelva, Not set
Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico, Jaen, Not set
Centro Oncológico Gallego José Antonio Quiroga y Piñeiro, Servicio de Oncologia, La Coruna, Not set
Centro Oncologico MD Anderson Internacional, Madrid, Not set
Hospital Ramon y Cajal, Madrid, Not set
Hospital Universitario Clínico San Carlos, Madrid, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Not set
Hospital General Universitario J.M Morales Meseguer, Murcia, Not set
Hospital Clinico Universitario de Salamanca, Salamanca, Not set
Hospital Universitario Virgen Macarena, Sevilla, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Hospital Univ. Nuestra Señora de Valme, Sevilla, Not set
Complejo Hospitalario de Toledo- H. Virgen de la Salud, Toledo, Not set
Instituto Valenciano Oncologia, Valencia, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia, Valencia, Not set
Hospital Universitario la Fe, Valencia, Not set
Hospital Universitario Miguel Servet, Zaragoza, Not set
Sahlgrenska Universitetssjukhuset, Goteborg, Not set
Uni Hospital Linkoeping, Linkoeping, Not set
Karolinska University Hospital, Stockholm, Not set
Norrlands Universitetssjukhus, Umeå, Cancercentrum, Umea, Not set
Akademiska sjukhuset, Onkologkliniken, Uppsala, Not set
Universitaetsspital Basel, Basel, Not set
Hôpitaux Universit. de Genève Gynécologique - Oncologie, Genève 14, Not set
Luzerner Kantonsspital, Luzern, Not set
Kantonsspital St. Gallen, St. Gallen, Not set
Brust-Zentrum Zürich AG Seefeldstrasse 214 Zürich, Zürich, Not set
Changhua Christian Hospital, Changhua, Not set
Kaohsiung Medical Uni Chung-Ho Hospital, Kaohsiung, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung Uni Hospital, Tainan, Not set
Veterans General Hospital, Taipei, Not set
National Taiwan Uni Hospital, Taipei, Not set
Tri-Service General Hospital, Division of General Surgery, Taipei, Not set
Chiang Rai Prachanukraw Hospital, Chiang Rai, Not set
Lopburi Cancer Hospital, Lopburi, Not set
Buddhachinaraj Phitsanulok Hospital, Phitsanulok, Not set
Songklanagarind Hospital, Songkla, Not set
Surat Thani Hospital, Surat Thani, Not set
Cherkassy Regional Oncological Hospital, Cherkassy, Not set
State Medical Academy, Dnipropetrovsk, Not set
Ivano-Frankivsk Regional Oncology Center, Ivano-Frankivsk, Not set
Kyiv City Clinical Oncological Center, Day Hospital Department for Oncological patients, Kiev, Not set
Volyn Regional Oncology Dispensary, Lutsk, Not set
Lvov State Regional Oncology Medical & Diagnostic Center, Lvov, Not set
Ternopil State Medical Academy, Ternopil, Not set
Royal Berkshire Hospital, Berkshire, Not set
Velindre Cancer Centre, Cardiff, Not set
Cheltenham General Hospital, Cheltenham, Not set
Colchester General Hospital, Colchester, Essex, Not set
University Hospital coventry, Coventry, Not set
Western General Hospital, Edinburgh, Not set
Royal Devon & Exeter Hospital, Exeter, Not set
Ipswich Hospital, Ipswich, Not set
St James Uni Hospital, Leeds, Not set
St. Bartholomew'S Hospital, London, Not set
UCL Hospital NHS Trust, London, Not set
Royal Marsden Hospital, London, Not set
Christie Hospital, Manchester, Not set
Mount Vernon Hospital, Northwood, Not set
Nottingham City Hospital, Nottingham, Not set
Churchill Hospital, Oxford, Not set
Peterborough City Hospital, Edith Cavell Campus, Peterborough, Not set
Queen Alexandra Hospital, Portsmouth, Not set
Royal Preston Hosp, Preston, Not set
Weston Park Hospital, Sheffield, Not set
Uni Hospital of North Staffordshire, Stoke-on-Trent, Not set
Royal Marsden Hosp NHS Fnd, Sutton, Not set
Royal Cornwall Hospital, Truro, Not set
The Clatterbridge Cancer Ctr For Oncolgy, Wirral, Not set
New Cross Hospital, Wolverhampton, Not set
Conditions: Breast Cancer
Study of Novel Treatment Combinations in Patients With Lung Cancer
Recruiting
The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Substudy-01 will compare the different novel combinations versus standard of care in participants with metastatic (cancer that has spread) non-small-cell lung cancer (NSCLC) who have not been treated before. Substudy-02 will compare the different novel combination versus standard of care in participants with cancer that has progressed after receiving previous treatment... Read More
The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Substudy-01 will compare the different novel combinations versus standard of care in participants with metastatic (cancer that has spread) non-small-cell lung cancer (NSCLC) who have not been treated before. Substudy-02 will compare the different novel combination versus standard of care in participants with cancer that has progressed after receiving previous treatment for metastatic NSCLC. Substudy-03 will compare the different novel combinations versus standard of care in participants with resectable stage II-III NSCLC.
The primary objectives of this study are:
Substudy-01 and Substudy-02: To evaluate the objective response rate (ORR) assessed per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1).
Substudy-03: To evaluate the efficacy of treatment combinations based on complete pathological response (pCR) rate. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/11/2025
Locations: Arizona Oncology Associates,Substudy-01, Tucson, Arizona +87 locations
Arizona Oncology Associates,Substudy-01, Tucson, Arizona
Arizona Oncology Associates,Substudy-02, Tucson, Arizona
Rocky Mountain Cancer Center,Substudy-01, Denver, Colorado
Rocky Mountain Cancer Center,Substudy-02, Denver, Colorado
Fort Wayne Medical Oncology and Hematology, Inc.,Substudy-03, Fort Wayne, Indiana
Baptist Health Lexington,Substudy-03, Lexington, Kentucky
Washington University School of Medicine - Siteman Cancer Center,Substudy-01, Saint Louis, Missouri
Washington University School of Medicine - Siteman Cancer Center,Substudy-02, Saint Louis, Missouri
Washington University School of Medicine - Siteman Cancer Center,Substudy-03, Saint Louis, Missouri
Washington University School of Medicine - Siteman Cancer Center, Saint Louis, Missouri
Oncology Hematology Care Clinical Trials, LLC,Substudy-01, Cincinnati, Ohio
Oncology Hematology Care Clinical Trials, LLC,Substudy-02, Cincinnati, Ohio
Oncology Associates of Oregon, PC,Substudy-01, Eugene, Oregon
Oncology Associates of Oregon, PC,Substudy-02, Eugene, Oregon
Texas Oncology - Central South,Substudy-01, Austin, Texas
Texas Oncology - Central South,Substudy-02, Austin, Texas
US Oncology Investigational Products Center (IPC),Substudy-01, Fairfax, Virginia
US Oncology Investigational Products Center (IPC),Substudy-02, Fairfax, Virginia
Fred Hutchinson Cancer Center,Substudy-01, Seattle, Washington
Fred Hutchinson Cancer Center,Substudy-02, Seattle, Washington
Centro Gaúcho Integrado de Oncologia Hematologia, Ensino e Pesquisa Ltda./Hospital Mãe de Deus,Substudy-03, Porto Alegre, Not set
Hospital Mae de Deus, Porto Alegre, Not set
Hospital Sao Lucas da PUC Rio Grande do Sul,Substudy-03, Porto Alegre, Not set
Fundação Antonio Prudente/A.C. Camargo Cancer Center,Substudy-03, São Paulo, Not set
Real e Benemérita Associação Portuguesa de Beneficência/Hospital Beneficência Portuguesa de São Paulo (Hospital BP),Substudy-03, São Paulo, Not set
Queen Mary Hospital,Substudy-01, Hong Kong, Not set
Queen Mary Hospital,Substudy-02, Hong Kong, Not set
Queen Elizabeth Hospital,Substudy-01, Hong Kong, Not set
Queen Elizabeth Hospital,Substudy-02, Hong Kong, Not set
Prince of Wales Hospital,Substudy-01, New Territories, Not set
Prince of Wales Hospital,Substudy-02, New Territories, Not set
Rambam Health Care Campus,Substudy-01, Haifa, Not set
Rambam Health Care Campus,Substudy-02, Haifa, Not set
Rambam Health Care Campus,Substudy-03, Haifa, Not set
Shaare Zedek Medical Center,Substudy-01, Jerusalem, Not set
Shaare Zedek Medical Center,Substudy-02, Jerusalem, Not set
Shaare Zedek Medical Center,Substudy-03, Jerusalem, Not set
Hadassah University Medical Center,Substudy-03, Jerusalem, Not set
Rabin Medical Center,Substudy-03, Petah Tiqva, Not set
Tel Aviv Sourasky Medical Center,Substudy-01, Tel Aviv-Yafo, Not set
Tel Aviv Sourasky Medical Center,Substudy-02, Tel Aviv-Yafo, Not set
Tel-Aviv Sourasky Medical Center,Substudy-03, Tel Aviv-Yafo, Not set
Chungbuk National University Hospital,Substudy-01, Cheongju-si, Not set
Chungbuk National University Hospital,Substudy-02, Cheongju-si, Not set
National Cancer Center,Substudy-01, Goyang, Not set
National Cancer Center,Substudy-02, Goyang, Not set
National Cancer Center,Substudy-03, Goyang, Not set
Chonnam National University Hwasun Hospital,Substudy-01, Gwangju, Not set
Chonnam National University Hwasun Hospital,Substudy-03, Gwangju, Not set
Seoul National University Bundang Hospital,Substudy-01, Gyeonggi-do, Not set
Seoul National University Bundang Hospital,Substudy-03, Gyeonggi-do, Not set
Kosin University Gospel Hospital,Substudy-01, Seo-gu, Not set
Kosin University Gospel Hospital,Substudy-03, Seo-gu, Not set
Severance Hospital, Yonsei University Health System,Substudy-03, Seoul, Not set
Asan Medical Center,Substudy-02, Seoul, Not set
Asan Medical Center,Substudy-03, Seoul, Not set
Asan Medical Centre,Substudy-01, Seoul, Not set
Samsung Medical Center,Substudy-01, Seoul, Not set
Samsung Medical Center,Substudy-02, Seoul, Not set
Samsung Medical Center,Substudy-03, Seoul, Not set
Severance Hospital, Yonsei University Health System,Substudy-01, Seoul, Not set
Severance Hospital, Yonsei University Health System,Substudy-02, Seoul, Not set
Seoul National University,Substudy-01, Seoul, Not set
Seoul National University,Substudy-02, Seoul, Not set
Korea University Guro Hospital,Substudy-01, Seoul, Not set
Korea University Guro Hospital,Substudy-03, Seoul, Not set
Changhua Christian Hospital,Substudy-01, Changhua City, Not set
Changhua Christian Hospital,Substudy-02, Changhua City, Not set
Changhua Christian Hospital,Substudy-03, Changhua City, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital,Substudy-01, Kaohsiung City, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital,Substudy-02, Kaohsiung City, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital,Substudy-03, Kaohsiung City, Not set
Kaohsiung Chang Gung Memorial Hospital,Substudy-01, Kaohsiung, Not set
Kaohsiung Chang Gung Memorial Hospital,Substudy-02, Kaohsiung, Not set
Kaohsiung Chang Gung Memorial Hospital,Substudy-03, Kaohsiung, Not set
National Taiwan University Hospital,Substudy-01, Taipei City, Not set
National Taiwan University Hospital,Substudy-02, Taipei City, Not set
Memorial Ankara Hospital,Substudy-03, Ankara, Not set
Dicle University Medical Faculty,Substudy-03, Diyarbakir, Not set
Necmettin Erbakan Universitesi,Substudy-03, Meram Konya, Not set
Gazi University Medical Faculty,Substudy-03, Yenimahalle, Not set
Birmingham Heartlands Hospital,Substudy-03, Birmingham, Not set
University Hospitals Birmingham NHS Trust,Substudy-01, Birmingham, Not set
University Hospitals Birmingham NHS Trust,Substudy-02, Birmingham, Not set
St James University Hospital,,Substudy-01, Leeds, Not set
St. Bartholomew's Hospital,Substudy-01, London, Not set
St. Bartholomew's Hospital,Substudy-02, London, Not set
St. Bartholomew's Hospital,Substudy-03, London, Not set
Conditions: Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Recruiting
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer Agents in Patients with Advanced/Metastatic Solid Tumours.
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer Agents in Patients with Advanced/Metastatic Solid Tumours. Read Less
Gender:
ALL
Ages:
Between 18 years and 130 years
Trial Updated:
07/10/2025
Locations: Research Site, Los Angeles, California +94 locations
Research Site, Los Angeles, California
Research Site, San Diego, California
Research Site, Santa Rosa, California
Research Site, Muncie, Indiana
Research Site, Kansas City, Kansas
Research Site, Boston, Massachusetts
Research Site, Boston, Massachusetts
Research Site, Grand Rapids, Michigan
Research Site, East Brunswick, New Jersey
Research Site, Albuquerque, New Mexico
Research Site, Commack, New York
Research Site, Cincinnati, Ohio
Research Site, Columbus, Ohio
Research Site, Portland, Oregon
Research Site, Nashville, Tennessee
Research Site, Nashville, Tennessee
Research Site, Houston, Texas
Research Site, Madison, Wisconsin
Research Site, Toronto, Ontario
Research Site, Toronto, Ontario
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Quebec, Not set
Research Site, Changsha, Not set
Research Site, Chongqing, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hefei, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Wuhan, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Zhengzhou, Not set
Research Site, Bordeaux, Not set
Research Site, Lyon, Not set
Research Site, Marseille, Not set
Research Site, Suresnes, Not set
Research Site, Berlin, Not set
Research Site, Essen, Not set
Research Site, Hannover, Not set
Research Site, München, Not set
Research Site, Regensburg, Not set
Research Site, Firenze, Not set
Research Site, Genova, Not set
Research Site, Milano, Not set
Research Site, Milano, Not set
Research Site, Milan, Not set
Research Site, Napoli, Not set
Research Site, Rome, Not set
Research Site, Chuo-ku, Not set
Research Site, Kashiwa, Not set
Research Site, Koto-ku, Not set
Research Site, Nagoya-shi, Not set
Research Site, Shinagawa-ku, Not set
Research Site, Suita-shi, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Gliwice, Not set
Research Site, Kraków, Not set
Research Site, Poznań, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, Barcelona, Not set
Research Site, Cordoba, Not set
Research Site, Madrid, Not set
Research Site, Málaga, Not set
Research Site, Pamplona, Not set
Research Site, Sevilla, Not set
Research Site, Basel, Not set
Research Site, Bellinzona, Not set
Research Site, St. Gallen, Not set
Research Site, Liou Ying Township, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Edirne, Not set
Research Site, Kadıkoy/Istanbul, Not set
Research Site, Karsiyaka, Not set
Research Site, Konya, Not set
Research Site, Pamukkale, Not set
Research Site, Samsun, Not set
Research Site, Cambridge, Not set
Research Site, Dundee, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Manchester, Not set
Conditions: Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Urothelial Cancer, Biliary Tract Cancer
49 - 60 of 302